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ABSTRACT OF THE THESIS
IDENTIFICATION OF GENES DOWNSTREAM OF ENDOTHELIN-3 SIGNALING:
CHARACTERIZATION OF WSB1 AND SPC12
by
Aniveny Ayala
Florida International University, 2001
Miami, Florida
Professor Lidia Kos, Major Professor
Signaling of endothelin-3 (Edn3) through its receptor, endothelin receptor B
(EdnrB), has been shown to be indispensable for the development of certain neural crest
derivatives. Since no research has been directed to investigate what the downstream
targets of this signaling pathway are, the purpose of this study was to identify and
characterize genes that are transcriptionally regulated by Edn3 signaling.
Data from Differential Display RT-PCR of Edn-3 induced cDNA vs. non-induced
cDNA obtained from primary neural crest cultures was analyzed. Thirty bands that were
differentially expressed were sequenced and submitted for a homology search (BLAST).
Among the genes identified were WSB 1 (a member of the SOCS family of negative
regulators) and SPC 12 (the smallest subunit, 12kDa, of mammalian signal peptidase).
Using whole-mount in-situ hybridization, the expression patterns of EdnrB,
WSB 1 and SPC 12 were characterized. WSB 1 and SPC 12 expression patterns were
found to overlap with that of EdnrB, suggesting that Edn3 might regulate the
transcription of these genes in specific neural crest derived lineages.
v
TABLE OF CONTENTS
CHAPTER PAGE
I. IN TR O D U C T IO N ........................................................................... 1
II. LITERATURE REVIEW...................................................................2
1. The neural crest............................................................................2
2. Endothelin-3 and Endothelin Receptor B..............................................6
3. The question..............................................................................13
4. Preliminary data: Differential Display RT-PCR.....................................15
III. METHODOLOGY.........................................................................17
1. Reamplification........................................................................17
2. Preparation of Clones..................................................................17
3. Sequencing..............................................................................19
4. Blasting.................................................................................19
5. Semiquantitative RT-PCR............................................................20
6. Image clones...........................................................................21
7. Isolation of Plasmid DNA............................................................24
8. Riboprobe synthesis...................................................................24
9. Whole-mount in-situ hybridization.................................................25
10. Cryosectioning.........................................................................27
IV . R E SU L TS ................................................................................... 27
1. Expression pattern of EdnrB..........................................................28
2. Identification of differentially expressed bands after
induction with Edn3.....................................................................30
3. Semiquantitative RT-PCR.............................................................36
4. Characterization of WSBI and SPC12 using whole
mount in-situ hybridization.............................................................36
WSB1 expression pattern.........................................................38
SPC12 expression pattern........................................................38
V . D ISC U SSIO N ............................................................................... 41
1. WSB1: A member of the SOCS family of negative regulators..................41
SOCS: Suppressors of cytokine signaling.....................................42
WSB1 and WSB2.................................................................46
WSB 1 as a downstream target of Edn3 signaling............................48
2. SPC 12: the smallest subunit (12kDa) of the signal peptidase complex........50
3. Concluding Remarks..................................................................52
V I. R EFER EN C E S.............................................................................54
V II. A PPEN D IC E S .............................................................................. 62
Vi
LIST OF FIGURES
FIGURE PAGE
1. T he N eural C rest............................................................................ 3
2. Differential Display RT-PCR Gel........................................................ 18
3. EdnrB expression pattern.................................................................. 29
4. Semiquantitative RT-PCR of WSB1.................................................... 37
5. Semiquantitative RT-PCR of SPC12.................................................... 37
6. WSB1 expression pattern.................................................................. 39
7. WSB2 expression pattern.................................................................. 40
8. SPC12 expression pattern.................................................................. 41
9. SO C S proteins.............................................................................. 45
v11
I. INTRODUCTION
Hirschsprung disease, a congenital disease characterized by lack of enteric
ganglia and abnormal pigmentation pattern, has an incidence of 1:5000 in live births.
People suffering from this disease show patches of skin with no pigment and develop
megacolon as a result of the lack of innervation of their distal colon, indicating that the
normal development of melanocytes (pigment producing cells) and enteric neurons has
been altered. When the loci of genes mutated in Hirschsprung disease cases were
identified, a new door for research was opened. Mutations in the loci coding for
Endothelin-3 (Edn3) and its receptor, endothelin receptor B (EdnrB) have since been held
responsible for the aberrant phenotype and the signaling cascade they trigger considered
essential for the proper development of the neural crest derivatives affected: melanocytes
and enteric neurons. Many studies have demonstrated that addition of Edn3 to neural
crest cultures increases proliferation and might favor differentiation of melanocytes but
might also delay the differentiation of enteric neurons. In situ-hybridization studies of
the expression pattern of EdnrB and Edn3 during embryogenesis have shown that cells
from neural crest derived lineages express EdnrB while Edn3 is expressed in the
environment through which these cells migrate. Transgenic studies attempting to rescue
the wild type phenotype in mutant mice and rats (suffering from aganglionosis and
pigmentation defects) had Edn3 and EdnrB loci placed under control of promoters such
as dopamine-p-hydroxylase (DPH) and tetracycline-dependent transactivators (tTa or
rtTA), respectively. They were able to determine that the Edn3/EdnrB signaling pathway
is required from lOdpc (days post coitus) through 12.5dpc for the proper development of
melanocytes and enteric neurons, which is consistent with previous understanding that
melanoblasts and enteric neuroblasts begin their migration at about the same time.
Moreover, Edn3 has been widely hypothesized to prevent immature differentiation of
melanoblasts and neuroblasts until they reach their final destination. However, there has
not been any active research investigating what the downstream targets of the
Edn3/EdnrB signaling pathway are at a genetic and molecular level. Therefore, the
purpose of study was to identify and characterize genes that are transcriptionally
regulated by the biochemical pathway that Edn3 signaling elicits.
II. LITERATURE REVIEW
1. The neural crest.
During the early steps of embryogenesis, a large central region of the ectoderm
(neural plate) thickens, rolls up into a tube and pinches off from the rest of the ectodermal
sheet (epidermis) in a process known as neurulation. The newly formed neural tube gives
rise to the central nervous system. Following neurulation, a distinct group of cells
originates at the dorsalmost region of the neural tube, in between the neural plate and the
epidermis. These cells, widely known as neural crest cells, delaminate and subsequently
migrate throughout the vertebrate embryo, ultimately differentiating into numerous cell
types along their characteristic migratory paths (Weston, 1963).
Neural crest cells (NCC) are initially pluripotent, yielding a large variety of
derivatives including melanocytes, PNS neurons, glia, endocrine cells, bone, cartilage,
chromaffin cells (reviewed by Le Douarin, 1993) and smooth muscle cells (reviewed by
Anderson, 1997). However, their migratory behavior, together with the axial level at
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Figure 1. The Neural Crest. Diagramatic representation of the
pathways that trunk neural crest cells (red) follow as they migrate
from the dorsalmost region of the closing neural tube (NT). Also
labeled are the ectoderm (Ec), dermomyotome (DM), sclerotome
(Scl), notochord (No) and the developing aorta (Ao) (from
Gilbert, 2000).
which they arise and the final environment to which their cell derivatives localize are
very closely related to their diversification (Le Douarin, 1986). For example, only
cephalic neural crest forms the dermis, the membrane, cartilage, and bones of the skull
vault, the skull basis, and the face (reviewed by Le Douarin, 1993). NCCs arising at the
level of the hindbrain give rise to bone, cartilage and sensory neurons; and, smooth
muscle, enteric neurons and endocrine cells (thyroid) are derivatives of vagal neural crest
only (Le Douarin, 1982). Trunk NCCs differentiate into neurons and glia of sensory and
autonomic ganglia (reviewed by Groves and Anderson, 1996) and follow two major
pathways of migration, a ventral pathway through the rostral half of the somites and a
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dorsolateral pathway between the dermomyotome and the epidermis (Figure 1).
Interestingly, melanocyte and glia (Schwann cells) are common derivatives of all axial
levels.
Classical embryological studies performed mainly in avian embryos and clonal
studies have shown that the process of commitment and differentiation of the neural crest
cells is gradual, occurring as they migrate and reach their final targets (Le Douarin et al.,
1994). A variety of precursors with more restricted potentials arise along the way, such
as one committed only to giving rise to glia and melanocytes (Le Douarin et al., 1994;
Gilbert, 1997).
The differentiation of NCCs involves an interaction between intrinsic and
extrinsic signals. Extrinsic signals are usually molecules that affect cell-intrinsic
regulators that in turn modulate how the cell might respond to the extracellular
environment (Groves and Anderson, 1996). Extrinsic signals can act as instructive or
permissive factors (Gilbert, 2000). Instructive factors directly influence the fate a cell
acquires during its process of differentiation. An example of an instructive factor is
BMP2 (bone morphogenetic factor 2), a member of the TGFP (transforming growth
factor-P) superfamily, which forms neurons at the expense of glial cells (Shah et al.,
1996). Permissive factors, such as fibronectin, are those which provide the right
environment without directing a cell to its final fate. For example, many cells require a
solid substrate containing fibronectin or laminin in order to develop and grow.
Fibronectin or laminin do not change the type of cell that is produced, but rather allow
the cell to express what has been determined to be expressed.
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Intrinsic regulation is based on the activity of transcription factors which trigger a
cascade of regulatory genes that can help specify cell fate in general, and cell identity
more precisely (Jan and Jan, 1995).
An alteration of any of these regulatory pathways, such as naturally occurring or
targeted mutations, could possibly cause a defect in various neural crest-derived cell
lineages. Developmental biologists use these mutations to study the different steps
involved in neural crest development: determination, migration, colonization,
differentiation, and survival (Le Douarin et al., 1994). For instance, mutations present in
genes encoding the c-Kit receptor tyrosine kinase and its extracellular ligand, Steel factor,
result in fertility and hematopoietic defects as well as a 'patchy' phenotype, with patches
of non-pigmented skin due to a failure in melanocyte precursors survival. Mice
displaying these phenotypes have been named Dominant white spotting (W) and Steel
(Sl), respectively (Jackson, 1991). Mutations in the c-Ret receptor tyrosine kinase result
in a megacolon phenotype due to a failure of the enteric ganglion neurons to populate the
distal part of the gut (Schuchardt et al., 1994). Mutations in transcription factors such as
Pax3 result in hypopigmentation, deafness, skeletal muscle and neural tube defects in
Splotch mice (Sp). A mutation in Mitf (also a transcription factor) has also been found to
be responsible for hypopigmentation, deafness and retinal defects of Micropthalmia (Mi)
mice (reviewed by Barsh, 1996; Jackson, 1997); and, mutations affecting the ErbB family
of receptors (ErbB2 and ErbB3) and their ligand neuregulin-1, result in severe deficits of
Schwann cells, another NCC derivative (Riethmacher et al., 1997).
All these mutations give us a sense of the importance of ligands and receptors in
initiating a flow of biochemical reactions in order for the cell to respond to its
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surrounding environment. When one of these components is ablated, the signaling
pathway to which it belongs is interrupted and, therefore, the normal development and
differentiation of neural crest cells that are dependent on this pathway are also affected.
Such is also the case of other two mutations that have been linked to neural crest
derivatives defects. Lethal spotting (is) and piebald-lethal (sl) mice are a result of
mutations in the genes encoding Endothelin-3 (Edn3) and its receptor Endothelin
receptor-B (EdnrB), respectively. Both mutant phenotypes are characterized by an
abnormal pigmentation pattern with varying degrees of pigment loss and an aganglionic
megacolon as a result of faulty melanocyte development and a defect in neural crest
derived neuronal colonization of the hindgut (Baynash et al., 1994; Hosoda et al., 1994).
EdnrB mutations have also been identified in the rat as responsible for the spotting lethal
condition (Ceccherini et al., 1995; Gariepy et al., 1996; Shin et al., 1997) and in the horse
for the lethal white foal syndrome (Santschi et al., 1998). In humans, EDNRB, has been
found to be mutated in 5% of the cases of Hirschsprung disease Type II characterized by
almost identical phenotypes as those found in the mouse (Chakravarti, 1996;
Puffenberger et al., 1994). Homozygous mutations in EDN3 have been linked to a
combination of Waardenburg syndrome Type II and Hirschsprung disease phenotype,
referred to as Shah-Waardenburg syndrome. Patients with Shah-Waardenburg syndrome
exhibit depigmentation as well as deafness (Hofstra et al., 1996).
2. Endothelin-3 and Endothelin Receptor-B.
Endothelins were first identified when a potent vasoconstrictor precursor peptide
was isolated from culture supernatant of porcine aortic endothelial cells. This precursor
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peptide, preproendothelin, undergoes proteolytical processing producing a mature 21-
amino acid peptide (endothelin) that was found to be secreted by endothelial cells once
they are exposed to various physical and chemical stimuli such as noradrenaline,
thrombin, hypoxia and mechanical stretch (Yanagisawa et al.,, 1988).
The porcine preproendothelin cDNA was cloned and sequenced (Yanagisawa et
al.1, 1988) and shortly after, both human (Itoh et al., 1988) and rat (Yanagisawa et al. 2 ,
1988) preproendothelins were also cloned and sequenced. Originally, the differences
among them were thought to be due to species variation until 1989 when Inoue et al.
made a distinction among three isopeptides encoded by different genes in the mammalian
genome but all with 'endothelin-like' sequences. The original endothelial derived
porcine endothelin and the human endothelin were named "endothelin-1". The rat
endothelin was named "endothelin-3" and a human endothelin-3 was later cloned (Bloch
et al., 1989). The third endothelin gene sequence discovered by this group was named
"endothelin-2".
Endothelin-1, endothelin-2 and/or endothelin-3 found in humans, pigs, rats and
later in mice and dogs share the same disulfide bonding. Although all of them are 21-
residue peptides, they differ from each other in amino acid composition (reviewed by
Phillips et al., 1992). For example, endothelin-1 has the same amino acid sequence in all
five species mentioned before. Mouse and human endothelin-2 differ by only one amino
acid but differ from endothelin-1 by three and two amino acids respectively. Endothelin-
3 from rats and humans have identical amino acid sequences but differ from endothelin-1
by six amino acids (Phillips et al., 1992).
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Numerous studies identified two subtypes of receptors for the three types of
endothelin. Endothelin receptor A (EdnrA) was found to have high affinity for
endothelin-1 and endothelin-2 but not endothelin-3, whereas endothelin receptor B
(EdnrB) can bind all three types of endothelin (Takayanagi et al., 1991). EdnrB and
EdnrA were further characterized as G-coupled seven transmembrane receptors (Hosoda
et al., 1994).
Despite the fact that all three types of endothelin act as vasoconstrictors, it has
been established that they have different functions during embryonic development. For
instance, signaling of Edn-1 through EdnrA plays an important role in the development of
cardiac neural crest cells. Embryos deficient for both EdnrA and Edn-1 display defects in
craniofacial structures, great vessels, and cardiac outflow tract (Clouthier et al., 1998;
Kurihara et al., 1994). Also, it has been found that the Edn-1/EdnrA signaling pathway
plays an essential role in aortic patterning by affecting postmigratory cardiac neural crest
cell development (Yanagisawa et al., 1998).
Similarly to the Edn-1/EdnrA signaling pathway, the Edn-3/EdnrB signaling
pathway has been found to be indispensable for the proper embryonic development of
neural crest derivatives such as, melanocytes and enteric neurons. As mentioned before,
mutations in mouse Edn3 and EdnrB result in the lethal spotting (ls) and piebald lethal
(s) phenotypes, respectively, both of which exhibit lack of enteric ganglia and abnormal
pigmentation. Since the development of these cell types is affected by the disruption of
the Edn3/EdnrB signaling pathway, the specific stages in development in which it is
necessary as well as its mode of action, at a cellular level and at a molecular level, are
still a matter of investigation.
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Analysis of the temporal and spatial pattern of Edn3 and EdnrB in mouse
embryos have shown that Edn3 is expressed in distal and proximal gut mesenchyme
throughout embryonic days 10-14 (10-14dpc) with stronger expression in the caecum
(10-12dpc) at about the same time that EdnrB expressing neural crest cells arrive at the
site (Leibl, et al., 1999). Studies on EdnrB expression on avian neural crest have shown
that it is expressed by cells of the neuroepithelium just as the neural tube begins to fold at
the level of the mesencephalon. It was also noted that EdnrB expression was especially
intense in the neural folds that later yield neural crest cells, depending on the rostro-
caudal level considered (Nataf et al., 1996). Later in development EdnrB positive cells
were found in dorsal root ganglia (DRG) and sympathetic ganglia (SG) at the trunk level,
in cranial nerves and associated sensory ganglia at the cephalic level, in Schwann cells
lining the peripheral nerves and in the adrenal medulla up to E8 in quail (Nataf et al.,
1996). EdnrB was also found to be expressed by vagal neural crest cells during their
migration and after they formed the Auerbach's and Meissner's plexuses of the gut wall
and in the post-umbilical gut caudal to the ileocaecal junction from E6 onward (Nataf et
al., 1996) during the colonization of the gut as described previously (Le Douarin and
Teillet, 1973). The expression pattern of EdnrB in mouse embryos is similar to that of
avian embryos (Southard-Smith et al., 1998) but a detailed temporal analysis is missing.
Since EdnrB and Edn3 are expressed from E8 onwards, the phenotypes observed
in the EdnrB/Edn3 mutants could be due to the disruption of their signaling pathway at
any of the stages of melanocyte and enteric development. Therefore, the EdnrB/Edn3
signaling pathway may be affecting neural crest precursors as they start migrating, after
their lineages have segregated or after they have reached their final targets. Early studies
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on piebald mice conducted by Mayer (1965) in which he grafted embryonic neural tube
and skin of piebald and wild type mouse embryos to White Leghorn chick embryos,
demonstrated that melanoblasts differentiate only in the tissue environment of hair
follicles. He proposed that the 'piebald gene' (now identified as mutant EdnrB) renders
melanoblasts more sensitive to different levels of melanogenic stimuli and, therefore,
piebald melanoblasts would not be able to differentiate unless they find themselves in an
environment of high melanocytic activity such as the hair follicle. In order to support this
hypothesis, Mayer (1967) conducted a second experiment to test if the lack of pigment
observed in piebald mice was a result of a failure in migration or as he had proposed
before, due to a failure in melanoblast differentiation. Using the same technique, he
grafted 9dpc neural tube and 11dpc skin explants from wild type and piebald mouse
embryos into combination to chick emryos. After 15 days of incubation he examined
pigment production and migration of neural tube cells using tritiated thymidine and
autoradiography. Grafts of wild-type neural tubes and wild-type skin produced
pigmented hair whereas grafts of piebald neural tubes and piebald skin produced pigment
free hair. However, the pattern of migration of labeled wild type melanoblasts was
identical to that of piebald melanoblasts which favors Mayer's hypothesis that the coat
spotting present in piebald mice is due to a failure of melanoblasts differentiation in
certain tissue environments, not a failure in their migration.
In a more recent study conducted by Pavan and Tilghman (1994), melanocyte
development in piebald lethal embryos was examined using tyrosine related protein-2
(Trp-2) as an early maker for melanoblasts. They found that the number of Trp-2+ cells
was significantly lower in piebald embryos at 10.5dpc than in wild type embryos
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suggesting that this difference in number represents the earliest indication of the piebald
gene's activity and that the wild type gene (EdnrB) must act very early in melanocyte
development, before or at the same time as neural crest migration.
After the lethal spotting and the piebald lethal loci were identified (Edn3 and
EdnrB, respectively), numerous transgenic studies were directed to find out the time of
action of the genes involved in the development of the cell types affected (melanocytes
and enteric neurons). Transgenic studies using the human dopamine-p-hydroxylase
(DPH) promoter' to direct expression of EdnrB in spotting lethal (sl/sl) rats demonstrated
that EdnrB is necessary for the development of enteric neurons at a different time than it
is for melanocytes. In this study, researchers were able to prevent aganglionosis but were
not able to prevent color coat spotting suggesting that the time of action of EdnrB on
enteric neurons happens after melanocytes have diverged from their common precursor
(Gariepy et al., 1998). In contrast with the previous study, a different group had the
EdnrB locus under the control of tetracycline-dependant transactivators, tTA or rtTA in
mice (Shin et al., 1999). This group was able to pin-point a specific time period during
which EdnrB expression is necessary for the regular development of both, melanoblasts
and enteric neurons. They found EdnrB expression is required between lOdpc and
12.5dpc for the development of enteric neurons and melanoblasts, which coincides with
the time when they begin migrating from the MSA (migrating stage area)2. To further
support Shin's conclusion, another group used a dopamine-p-hydroxylase (DPH)
D H activity begins at 9.5dpc, continues throughout gut colonization and persists postnatally in a subset
of enteric neurons.
2 The MSA (migrating stage area) is an area lateral to the neural tube where neural crest derived
melanoblasts presumably remain for 24 hours before they begin their migration (lOdpc) (Shin et al., 1999).
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promoter to control the expression of Edn3 and Ret (receptor tyrosine kinase), which has
also been identified as necessary for the development of enteric neural crest lineage
together with its ligand gdnf (glial-cell derived neurotrophic factor). When they used
homozygous lethal spotting (is/s) mouse embryos to determine if the transgene would
compensate for the Edn3 defficiency, they found that the DPH-Edn3 transgene was able
to prevent aganglionosis and piebaldism showing that the timing is the same for both
lineages, whereas DPH-Ret was not. They also found that Edn3 signaling is necessary
for enteric neuroblasts once they reach the gut and as they begin colonization, implying
that Edn3 might prevent precursor cells from differentiating until they reach their target
position (Rice et al., 2000).
Since Edn3 expression was localized to the environment surrounding NCCs
(Nataf et al., 1998), many studies were devoted to investigating what the effects of Edn3
would be in vitro, especially on melanocytes and enteric neurons, the two cell types
affected by mutations in Edn3 and EdnrB. Lahav et al. (1996), found that Edn3 acts as a
proliferating agent of avian NCCs, greatly increasing the number of melanocytes in
primary neural crest cultures. Similar results were obtained for mouse neural crest
cultures which showed that Edn3 induces the proliferation and aids in the survival of
melanocyte progenitors in conjunction with the signaling of steel factor through the c-kit
receptor (Reid et al., 1996). Their study also pointed out that Edn3 (but not Edni)
induces neural crest cells pigmentation suggesting that Edn3 plays a role in the final
differentiation of melanocytes. However, studies by Stone et al. (1997) using clonal
analysis, concluded that although there was an increase in the number of neural crest
cells, these were not only melanoblasts and melanocytes but also multipotent precursors
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yielding more than one cell type. Their results suggest that Edn3 acts on two types of
precursors: those giving rise to melanocytes, adrenergic cells and sensory-like cells, and
those giving rise to melanocytes and Schwann cells. Their results also suggest that Edn3
inhibits the final differentiation of precursor cells and prevents their loss of
developmental potential. This suggests that, in the case of melanoblasts, it keeps them
undifferentiated until they reach their final destination. Furthermore, a study conducted
by Opdecamp et al. (1998) revealed that melanoblasts did not differentiate or proliferate
unless subjected to treatment with any of the three types of endothelin. Once endothelins
were added to neural crest cultures the number of melanoblasts and melanocytes
increased significantly. This was consistent with an early finding that endothelins acted
on signal transduction and proliferation in human melanocytes based on the observation
that DNA synthesis as well as melanin synthesis (characteristics of a proliferative agent)
were stimulated by endothelins (Yada et al., 1991). Not only has Edn3 been shown to
increase the number of melanocytes, it has also been found to induce the reversion of
melanocytes to glia via a glia-melanocyte progenitor (Dupin et al., 2000). Nevertheless,
Wu et al. (1999) used crest derived fetal gut cells and demonstrated that Edn3 did not
have the same effect on mammalian precursors of enteric neurons. It actually decreased
the number of NC derived neurons and induced the development of enteric smooth
muscle. They proposed that Edn3 prevents immature differentiation of precursors until
they colonize the gut, an idea previously described by Stone et al. (1997).
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3. The question.
Although there is overwhelming data indicating that many neural crest derivatives
depend upon Edn3 signaling through EdnrB, there is little information on what happens
downstream of this pathway.
As mentioned before, EdnrB and EdnrA have been identified as seven-
transmembrane G-coupled receptors. Early studies on signal transduction in fibroblasts
found that Edni stimulated proliferation through transduction associated with inositol
phosphate (Kusuhara et al., 1989). Subsequent studies on human melanocytes found that
levels of inositol triphosphate (IP 3) and intracellular calcium were substantially increased
after the addition of Ednl, Edn2 and Edn3 to melanocytes cultures. In addition,
endothelins stimulated DNA and melanin synthesis as well as increase proliferation of
melanocytes (Yada et al., 1991). Later studies demonstrated that EdnrB binds all three
endothelins and is coupled to heterotrimeric G proteins (Aramori and Nakanishi, 1992;
Takagi et al., 1995). Vichi et al. (1999) showed that the seventh transmembrane domain
(TMD7) of EdnrB regulates the AP-1 3 (active gene regulation protein) transcriptional
3 Some G coupled receptors, such as EdnrB, activate phopho-inositide specific phopholipase C. This
enzyme cleaves PIP2 (phosphatidylinositol biphosphate) to generate IP 3 (inositol triphosphate) and DAG
(diacylglycerol). IP 3 leaves the plasma membrane and binds to Ca2+ channels in the endoplasmic reticulum
(ER) which triggers the release of Ca2+ into the cytosol. The biological significance of Ca2+ release is still
unclear. On the other hand, DAG can be further cleaved to arachidonic acid which can act as a messenger
or be used in the synthesis of eicosanoids. But most importantly, DAG activates a crucial serine/threonine
protein kinase, pkC, which phosphorylates selected proteins in the cell. The initial rise in cytosolic Ca2+
causes pkC to translocate from the cytosol to the cytoplasmic side of the plasma membrane where it is
activated by DAG, Ca2+ and phospholipid phophatidylserine. PkC then goes on to regulate transcription in
either of two ways: it can activate an inhibitor protein which releases a gene regulatory protein or it can
activate other kinases such as a MAP kinase which in turn activates regulatory gene proteins. One
important member of MAP kinase transcriptional activation is the complex formed by Elk-1 and serum
response factor (SRF) which is bound to the regulatory region of thefos gene. Activation of this complex
leads to transcription offos. Alternatively, MAP kinases can activate Jun proteins which combine with the
newly made Fos protein to form the active gene regulatory protein called AP-1. AP-1 turns on additional
genes, although its role in cell proliferation is still unclear (Alberts et al., 1994).
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pathway and that the cytoplasmic tail of the receptor is involved in selective Gq
coupling.4 It has also been found that the third intracellular loop of EdnrB is important for
Gi coupling involved in the inhibition of the cyclic AMP pathway, and that it does not
interfere with Gq coupling (Auricchio et al., 1999). More recent studies found that
optimal signal transduction through EdnrB depends on Gq coupling rather than on Go or
Gi coupling (Imamura et al., 2000). However, the most recent study on EdnrB signal
transduction showed that Gi coupling and therefore, cAMP activity, might also be
important for intracellular signaling leading to neural crest cell derived neuron and glial
differentiation (Fuchs et al., 2001).
In spite of all this information on EdnrB signal transduction, no research has been
conducted to identify downstream targets of EdnrB mediated signaling of Edn3.
Consequently, this study has been concentrated on identifying such transcriptionally
regulated targets which follow Edn3/EdnrB signaling.
4. Preliminary data: Differential Display
Differential Display (DD) RT-PCR was the method chosen to identify genes that are
transcriptionally modified downstream of the Edn3/EdnrB signaling pathway. Primary
neural tube cultures from 9.5dpc mouse embryos were established. Sixty-one cultures
were induced with Edn3 and eighty-four cultures were not induced. Both sets of cultures
were incubated at 37°C for a two-day period after which RNA was extracted.
Approximately 855ng of RNA were obtained from the non-induced cultures and
4 The major signaling pathway after EdnrB activation follows Gq couplin , increase in intracellular Ca>
concentrations and activation of a Jun N-terminal kinase (JNK). The minor signaling pathway involves
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8 8 8.75ng were obtained from cultures induced with Edn3. The extracted RNA was
subjected to RT-PCR using anchoring primers specially designed to bind to the poly-A
tail of mRNA and the immediate nucleotide upstream of the poly-A tail. These primers
were labeled H-T 11G, H-T 1 1A and H-T1 1 C. Each one of them contains 11 T's
(complementary to the poly-A tail) and an anchoring G, A, or C designed to bind a C, T,
or G, respectively, that might be found immediately upstream the poly-A tail.
The cDNA obtained from RT-PCR was then amplified using the same anchoring
primers used for the previous reaction together with arbitrary primers designed to bind
consensus promoter sequences. The eight arbitrary primers used were labeled AP,
through AP8 . Both sets of primers were part of a Differential Display kit obtained from
GenHunter.
The products of this amplification were run in a 6% polyacrylamide gel creating a
characteristic 'fingerprint' of the initial mRNA. Products from induced and non-induced
cultures were loaded in contiguous lanes (induced: right, non-induced:left) to facilitate
the identification of differentially expressed bands. If a band in the 'induced' lane appears
darker or lighter than in the 'non-induced' lane it denoted upregulation or downregulation
after induction of Edn3, respectively. A picture of the Differential Display Gel is shown
in Figure 2. Forty-eight differentially expressed bands were selected for analyses. Thirty
bands of the forty-eight selected were analyzed in this study. Glycerol stocks of clones
containing bands 25, 28, 38, 39 and 48 had been established prior to the beginning of this
project, but were also analyzed and included in this investigation.
activation of Ga which inhibits adenylate cyclase (Fuchs et al., 2001).
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III. METHODOLOGY.
1. Re-amplification.
To avoid any artifacts and to confirm the amplification of differentially expressed bands,
25 bands were subjected to re-amplification. Bands 4, 6, 9, 17, 18, 21, 26, 27, 29, 30, 31,
32, 33, 34, 35, 35, 36, 37, 40, 41, 42, 43, 44, 45, 46, and 47 were re-amplified using the
same anchoring primers used for DD-RT PCR obtained from GenHunter.
The primers used for re-amplification of these 25 bands were:
" Arbitrary primers: API, AP2, AP3, AP4, AP5, AP6, and AP8
" Anchoring primer: H-T IC
The same anchoring primer, H-T 1iC, was used for all re-amplification reactions. API
was used to amplify bands 4, 9, 29, 30, and 31. AP2 was used to amplify bands 6, 32, and
33. AP 3 was used to amplify bands 34, 35, 36, and 37. AP4 was used to amplify band 40.
AP5 was used to amplify bands 41, 42, 43, 44, and 45. AP 6 was used to amplify bands
17, 18, 21, 46, and 47. APs was used to amplify bands 26 and 28.
All PCR reactions underwent the same thermocycle: (1) 94°C x 5' (2) 94*C x 30" (3)
40°C x 2' (4) 72*C x 1' (5) Go to 2 x 40 (6) 72*C x 5' (7) 4°C forever.
All PCR products were run in a 1% agarose gel to check for re-amplification. Only
eleven bands were successfully re-amplified.
2. Preparation of clones.
Bands that were re-amplified were excised from the agarose gel and Gel Purified (Qvick)
according to the manufacturer's protocol. They were subsequently cloned into the pCR
II cloning vector (Invitrogen) following manufacturer's instructions. Transformed cells
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Figure 2. Differential Display RT-PCR Gel. The arbitrary primers (labeled P1.
8) and the oligo-dT primers (HT1iG, HTIA and HTIC) used for each lane are
shown at the top of the gel. Each pair of lanes contains cDNA obtained from
Edn-3 induced cultures (right lane) and non-induced cultures (left lane). Bands
that showed upregulation after induction with Edn-3 are darker in the 'induced'
lane whereas bands showing downregulation are lighter in the 'induced' lane.
Forty-eight bands that clearly displayed this difference were selected for
analysis.
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were plated on LB plates containing X-gal and ampicillin and left to grow overnight at
37°C. White colonies were picked and grown overnight in LB with ampicillin
(100ug/mL). Plasmid DNA was isolated the following day using a SV Miniprep kit
(Promega) and quantitated with a spectrophotometer.
3. Sequencing.
200-700ng of plasmid DNA were used for each sequencing reaction together with 3ul
dilution buffer, 2ul primer M13 (F or R), 2ul Big Dye terminator and UV-treated dH20 to
complete a 20ul total volume. These samples were then subjected to the following
thermocycle: (1) 96°C x 30" (2) 50°C x 30" (3) 60°C x 3' (4) Go to 1 x 29 (5) 4°C forever.
One volume of 7M NH 4OAC (1 Oul) and 3 volumes of ETOH (90ul) were added to each
reaction, covered with aluminum foil to protect from light and left to precipitate
overnight at -20°C. The precipitate was centrifuged at 14000 rpm for 30min at 4°C, the
pellet washed with 70% ETOH and then air-dried. At this point the samples can be kept
as pellets at -20"C and when ready for sequencing, resuspended in 3ul of deionized
formamide:dextran (5:1). All samples were sequenced using an ABI 377 automatic
sequencer.
4. Blasting.
The sequences obtained from the ABI 377 were edited to delete the pCR II plasmid
sequence. The sequence of the inserts was then submitted to GenBank
(www.ncbi.nlm.nih.gov/Database/index.html) for a homology search (BLAST). The
inserts were blasted against a nucleotide database, a protein database as well as against an
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EST (Expressed Sequence Tags) database. Inserts corresponding to bands 28, 39 and 40
were selected for further characterization because to of their high homology to SPC12
and WSB1.
5. Semi-quantitative RT-PCR.
cDNAs from Edn3-induced cultures and from non-induced cultures were subjected to
semi-quantitative PCR to compare the amount of WSB1 (band no. 39) and SPC12 (band
no. 28) present in both of them. Primers were designed to target a fragment of this
sequence and for HPRTg, a housekeeping gene used as a control. All primers were
designed using Primer 3 software from The Whitehead Institute for Genomic Research
(www-genome.wi.mit.edu) and then ordered from Res Gen (Invitrogen - Life
Technologies). The primers ordered for semiquantitative PCR were:
" WSB1-R: 5'-TGAATGGGCCCTTTAGTTTTCTC-3' and WSB1-L: 5'-
CCCATGGTCTTAAAATAATTGTCCC-3' which yield a 458 bp product size that is
part of the 2463 bp cDNA sequence of WSB-1 (accession number: NM019653),
starting at position 1819 and ending at position 2276. The scale of synthesis was 50n
mol. The PCR cycle used was: (1) 94"C x 5' (2) 94°C x 1' (3) 58"C x 1' (4) 72"C x
1' (5) Go to 2 x 44 (6) 72°C x 10' (7) 4"C forever.
* SPC12-L: 5'-CAAGGGGCAGAAACTAGCTG-3' and SPC12-R: 5'-
CACACGGGAAAGAAGCATTG-3' which yield a 510 bp product size that is part of
the 703 bp full cDNA sequence obtained from the pancreas of a 10 day old mouse
(accession number: AK007336). The starting position was 166 and ending at base
675. The scale of synthesis was 50nmol. The PCR cycle for the amplification of this
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fragment was: (1) 94"C x 5'(2) 94°C x 1' (3) 55"C x 1' (4) 72"C x 1' (5) Go to 2 x 44
(6) 72"C x 10' (7) 4"C forever.
" HPRTg-L: 5'-AGGACTGAAAGACTTGCTCGA-3' and HPRTg-R: 5'-
GTAGCTCTTCAGTCTGATAAA-3' which yield a 200bp product size that is part of
HPRTg, a housekeeping gene. The scale of synthesis was 50n mol. The PCR cycle
for the amplification of this fragment was: (1) 94°C x 5' (2) 94°C x 1' (3) 58"C x 1'
(4) 72"C x 1' (5) Go to 2 x 44 (6) 72*C x 10' (7) 4"C forever.
Primers were resuspended to a concentration of 100mM in UV-treated H20. 1 Oul of this
solution was used to prepare a 10mM working stock. All primers were stored at -20"C.
6. Image clones.
For in-situ hybridization experiments, 1 or 2 ESTs (obtained from embryonic stages of
development) homologous to the three genes to be characterized (SPC 12, WSB1 and
ubiquitinol cytochrome c reductase) were selected to be used as probes. For comparison
purposes, another member of the SOCS (suppressor of cytokine signaling) family of
genes (of which WSB 1 is a member) was examined and an EST selected for it. Image
Clones containing these ESTs in mammalian vectors with sites for SP6, T7 and/or T3
polymerases were purchased from ResGen-Invitrogen Corporation. These are the image
clones purchased:
" Image clone # 4016049: contained WSB1-EST (Accession Number: BF140245)
inserted into pCMV-Sport6 cloning vector.
" Image clone# 3601047: contained WSB2-EST (Accession Number: BE382004)
inserted into pCMV-Sport6 cloning vector.
21
* Image clone# 1382191: contained 40a-EST (accession number: AI462067) inserted
into pT3T7d cloning vector.
* Image clone# 389242: contained 28-EST (accession number: W74994) inserted into
pT3T7d cloning vector.
" Image clone# 3025933: contained WSB1-EST (2) (accession number: AW744360)
inserted into pT3T7d cloning vector.
All image clones were provided as cultures in LB media with 8%glycerol. The cultures
were streaked on LB plates containing ampicillin and grown at 37°C overnight. The
image clones were stored at -80"C. The following day, twelve colonies were picked and
plated again on a new LB plate with ampicillin and grown at 37"C overnight. The
streaked plates were wrapped in parafilm and stored at 4"C. To determine which of the
12 colonies contained the insert, I performed 'colony-PCR'. A Master Mix for each
image clone was prepared containing 222.6u1 UV-treated and filtered dH20, 28u1 loX
buffer, 5.6ul dNTPs, 5.6ul primer #1, 5.6ul primer #2, and 5.6ul Taq polymerase. The
mix was then aliquoted into 13 tubes containing 19.5ul of the mix (12 for each colony
and 1 as control). The 12 colonies were picked and used to inoculate each of the
reactions. The samples were then subjected to their correspondent PCR cycle depending
on the set of primers used:
* Image clone # 4016049: WSB1-EST-L: 5'-GGATCAGCTACTCCTGCCAC-3' and
WSB1-EST-R: 5'-ACTCGCCTTGGTAGTGTGCT-3' which yield an 886 bp product
from the WSB1-EST cDNA (AN: BF140245) selected from the blasting results,
starting at position 16 through 901. The PCR cycle used for colony PCR was: (1)
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94°C x 10' (2) 94°C x 1' (3) 55"C x 1' (4) 72"C x 1' (5) Go to 2 x 30 (6) 72"C x
10' (7) 4"C forever.
" Image clone# 3601047: WSB2-EST-L: 5'-AAGGATTCGAAGCCAAGAGC-3' and
WSB2-EST-R: 5'-CAAACACACGGGTGTCAAAC-3' which yield a 604 bp product
from the WSB2-EST cDNA (AN: BE382004) selected from the blasting results,
starting at position 68 through 671. The PCR cycle used for colony PCR was: (1)
94"C x 10' (2) 94°C x 1' (3) 55"C x 1' (4) 72°C x 1' (5) Go to 2 x 30 (6) 72°C x
10' (7) 4"C forever.
" Image clone# 1382191: 40aEST-L: 5'-AGATGTGCATGCTAACAATGG-3' and
40aEST-R: 5'-TCTTCTGACATTACCTCACTGC-3' which yield a 313 bp product
from the 40a-EST cDNA (AN: A1462067) selected from blasting results, starting at
position 95 through 407. The PCR cycle used for colony PCR was: (1) 94"C x 10' (2)
94"C x 1' (3) 54°C x 1' (4) 72°C x 1' (5) Go to 2 x 35 (6) 72"C x 10' (7) 4°C forever.
" Image clone# 389242: 28EST-L: 5'-CCCCGCAAACTTTACTCCTT-3' and 28EST-
R: 5'-GGCGGTTTAAGCTCATGTTT-3' which yield a 465 bp product from the
28EST cDNA (AN: W74994) selected from blasting results, starting at position 13
through 477. The PCR cycle used for colony PCR was: (1) 94"C x 10' (2) 94"C x 1'
(3) 54°C x 1' (4) 72°C x 1' (5) Go to 2 x 35 (6) 72°C x 10' (7) 4"C forever.
" Image clone# 3025933: WSB 1-EST (2)-L: 5'-AGGAAGCTGGAAGGTCATCA-3'
and WSB1-EST(2)-R: 5'-GGCAGTCTTGGGACTTCTTG-3' which yield a 476 bp
product from the WSB 1-EST cDNA (AN: AW744360) selected from blasting results,
starting at position 46 through 521. The PCR cycle used for colony PCR was: (1)
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94"C x 10' (2) 94"C x l' (3) 54"C x 1' (4) 72C x 1' (5) Go to 2 x 35 (6) 72"C x 10'
(7) 4°C forever.
Upon completion of PCR, the samples were run in a 1.5% agarose gel to check which of
the 12 colonies contained the insert. If all colonies were positive for the insert, one of
them was selected randomly to inoculate LB (with amp) and grow overnight at 37°C. A
glycerol stock was created for each clone and stored at -80"C.
7. Isolation of Plasmid DNA.
After growing the clones overnight, plasmid DNA containing the inserts was isolated
using a SV Miniprep Kit (Promega) according to manufacturer's instructions. Plasmid
concentration was then measured using a SmartSpec spectrophotometer (Biorad).
In-situ hybridization.
8. Riboprobe synthesis.
About IOug of plasmid DNA was linearized with appropriate enzymes (EcoRI for
pCMV-Sport6 and XhoI for pT3T7d cloning vector) for lhr at 37"C. The linearized
plasmid template was incubated for another half an hour after the addition of 1 ul of
proteinase k (1 Omg/ml). Two phenol extractions and one of chloroform followed, as well
as ethanol precipitation overnight at -20"C. The following day, the samples were spun
down at 14 000 rpm for 30 minutes at 4"C and resuspended in lOul to a concentration of
1 ug/ul. One microliter was run in a 1.5% agarose gel to check for complete
linearization. The riboprobe synthesis reaction was set up as follows: lul linearized
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template (1 ug/ml), 2u1 1 OX transcription buffer, 2u1 dig-labeled NTPs mix, 2u1 RNA
polymerase (T7, T3 or SP6), lul RNAse inhibitor and 12ul DEPC H20. The reaction was
incubated at 37°C for 2hrs in a water bath. 2ul of 0.2M EDTA and 2.5ul of 4M LiCl
were added to stop the reaction and 75ul ETOH to precipitate nucleic acids. The samples
were centrifuged for 30 minutes at maximum speed (14 000 rpm) at 4°C, pellet was
washed with 70% ETOH in DEPC H20 and centrifuged again for 15 minutes under the
same conditions. The pellet was finally resuspended in 20u1 of DEPC H20 and one
microliter was run in a 1.5% agarose gel to compare the amount of RNA synthesized to
DNA left. All probes were stored at -20°C.
9. Whole mount in-situ hybridization
Embryos of ages 8.5dpc through 12.5dpc were dissected from C57BL/6J pregnant mice,
placed in 4m1 glass vials and fixed in 4% paraformaldehyde overnight. They were then
placed in 100% methanol and kept at -20°C. The whole mount in-situ hybridization
protocol that I used is divided into four days:
Dayl: Pretreatment and hybridization. Embryos were rehydrated through the following
dilutions of MeOH in PBT (PBS+0.1%Tween 20): 75%, 50% and 25% MeOH in PBT
for 5 minutes each and then washed with PBT twice. The embryos were then bleached
with 6% hydrogen peroxide in PBT for 1 hour while rocking at room temperature. Their
hindbrains were then punctured with the help of forceps and the embryos were
subsequently permeabilized with 1 Oug/ml proteinase K in PBT. Permeabilization times
were as follows: 8.5d: 15 minutes; 9.5d: 20 minutes; 10.5d: 25 minutes; 11.5d: 30
minutes; 12.5d: 35 minutes. The treatment was stopped with 2mg/ml glycine in PBT for
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10 minutes at room temperature while rocking. The embryos were washed with PBT
twice before post-fixing them with 4% paraformaldehyde, 0.2%gluteraldehyde in PBT
for 20 minutes at room temperature while rocking, and washed again twice with PBT.
They were placed in enough hybridization solution (50% formamide, 5X SSC pH4.5,
50ug/ml yeast tRNA, 1% SDS, 50ug/ml heparin) to cover them completely and were pre-
hybridized for at least an hour at 70°C. Embryos can be stored at this point at -20"C for a
long time. The hybridization solution was removed and new hybridization solution
containing the probe (about lug/ml) was added. Embryos were hybridized overnight at
70*C in a water bath.
Day 2: Washing and Antibody addition. Embryos were washed with freshly made
Solution 1 (50% formamide, 5X SSC pH 4.5, 1% SDS) three times for 30 minutes each at
70"C. They were then washed with also freshly made Solution 2 (50% formamide, 2X
SSC pH 4.5) three times for 30 minutes at 65*C and then washed another three times with
TBST (TBS+0.1% Tween 20) at room temperature for 5 minutes each. Embryos were
blocked in 10% goat serum (heat inactivated at 56"C for 1 hour) in TBST for 2 hours at
room temperature while rocking. Meanwhile, the anti-dig antibody was preabsorbed by
adding a tiny amount of embryo powder5 to 0.5ml of TBST for each in-situ vial and
heating at 70°C for 30 minutes, vortexing it and cooling in ice to finally add 5ul of goat
serum and 1 ul of anti-dig antibody. The antibody solution was then rocked at 4"C for 1
hour, pelleted and the supernatant was diluted with 1.5m1 of 1% goat serum in TBST.
3Embryo powder was obtained from homogenizing 12.5-14.5 embryos in cold PBS, adding 4 volumes of
cold acetone, mixing, and incubating on ice for 30 minutes. The mix was then centrifuged at 10 000g for
10 min after which the supernantant was removed, the pellet washed with cold acetone and spun again.
The pellet was spread out and grounded with a mortar and a pestle into a fine powder on a sheet of filter
paper. It was then air-dried and stored at 4"C.
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The blocking solution was removed from the embryos and replaced with the diluted
antibody solution. The embryos were left rocking overnight at 4*C.
Day 3: Washing antibody. The embryos were washed 3 times with TBST at room
temperature for 5 minutes each. They were then washed 5 times with TBST at room
temperature for 1 hour or more each. Levamisole (24mg/50ml) was added to the final
wash and the embryos were left rocking overnight at 4"C.
Day 4: Detection. Embryos were washed with NTMT (100mM NaCl, 100mM Tris pH
9.5, 50mM MgCl2, 0.1% Tween 20, 2mM levamisole) 3 times at room temperature for 10
minutes each. NTMT was removed and replaced with substrate solution (45ul NBT and
35u1 BCIP in 10ml NTMT). The vials were wrapped with aluminum foil to protect them
from light and monitored every half and hour under a dissecting scope. When detection
was complete they were washed in PBT twice and stored at 4"C in PBT. They were then
photographed in PBT using 160T Ektachrome Kodak film.
10. Cryosectioning.
Following whole mount in-situ hybridization, embryos were post fixed in 4%
paraformaldehyde at 4°C overnight while rocking. They were rocked in 10% sucrose at
4"C for 6 hours and left in 20% sucrose at 4°C overnight. The embryos were smeared
with OCT twice to get rid of any sucrose, mounted in a plastic mold and frozen at -80"C
for about 5 minutes or until the OCT completely solidified. They were mounted head up
on a mounting block by spreading some OCT, attaching the OCT block to it and letting it
freeze inside the Cryostat (chamber temperature: -20"C). More OCT was poured around
the block containing the embryo until it was firmly on the mounting block. All embryos
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were cross-sectioned at 30um. All sections were placed on glass slides and kept on a
slide warmer for 30 minutes. The slides were then mounted using water based mounting
media and sealed with clear nail polish. Sections were examined using a compound
microscope and some selected to be photographed using 160T Kodak film.
IV. RESULTS
1. Expression pattern of EdnrB.
Since the previously mentioned expression studies of EdnrB have mostly been done
on avian embryos, whole mount in-situ hybridization was performed on mouse embryos
using EdnrB as a probe in order to confirm the expression seen in the chick. The
digoxigenin-labeled riboprobes that were synthesized, hybridize to the complementary
mRNA found in the embryo. An anti-dig antibody conjugated with alkaline phosphatase
was used as part of the technique. Finally, development with alkaline phosphatase
substrates yields color where hybridization has occurred. Consequently, areas that
appeared to be dark purple in the embryos denoted hybridization of the probe to the
complementary mRNA transcript.
At 11.5 dpc, EdnrB expression was very strong in the ventricular zone of the brain
and spinal cord as well as in various neural crest derivatives such as trigeminal ganglion,
dorsal root ganglia, sympathetic ganglia, and the Schawnn cells lining of the peripheral
nerves (Fig. 3A). 12.5 dpc embryos showed that EdnrB continues to be expressed in the
ventricular zone of the brain and spinal cord, in the dorsal root ganglia, sympathetic
ganglia (and their projections) and in the trigeminal ganglion (Fig. 3B). Strong expression
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was also found in the heart and in the enteric neuron precursors colonizing the gut (Fig.
3B).
Figure 3. EdnrB expression pattern. Whole-mount in-situ hybridization of 11.5dpc
(A) and 12.5dpc (B,C) embryos. drg: dorsal root ganglia, fag: facio-acoustic ganglia, fb:
forebrain, h: heart, sg: sympathetic ganglia, arrow: enteric ganglia.
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2. Identification of differentially expressed bands after induction with Edn3.
In order to confirm the amplification of the bands selected from the Differential
Display Gel, they were re-amplified with the same primers used for their amplification
prior to running the gel. Only 11 bands (4, 9, 27, 30, 32, 34, 35, 37, 40, 44) out of 256
selected for the reaction were re-amplified and subsequently gel purified. The 11
fragments were cloned into the pCR-II cloning vector. Three clones from each cloning
reaction were grown, the plasmid containing the insert was isolated and sequenced to
check for possible amplification of more than one band by the primers and cycles used
for DD RT-PCR. Clones that were previously obtained from bands 25, 28 and 39 were
also sequenced. All sequences were submitted to GenBank for a nucleotide homology
search (BLAST). The results from the BLAST are presented in Table 1.
Since the fragments obtained from the Differential Display could belong to the
untranslated region (UTR) of a gene sequence, sequences that showed high homology to
uncharacterized cDNAs, were subjected to a secondary nucleotide blast. The results from
the secondary BLAST are shown in Table 2.
cDNA sequences that had no significant homology to any known gene or gene
family after the secondary blast were subjected to a translation BLAST to search for
protein homology and conserved protein domains (GenBank translates the nucleotide
sequence given and searches for homology against all translated sequences in the
database). The results from the translation BLAST are shown in Table 3.
6 The 25 bands subjected to re-amplification were: 4, 6, 9, 17, 18, 21, 26, 27, 29, 30, 31, 32, 33, 34, 35, 36,
37, 40, 41, 42, 43, 44, 45, 46, 47.
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BAND LONE PRIMARY BLAST SCORE e VALUE ACCESSION No UPREGULATED/
No. DOWNREGULATED
mRNA ribosomal protein S6 (Rsp6) 204 3 e-53 AK012284
a 10/11d embryo cDNA 204 3 e-53 AK013333
4 11 d embryo cDNA 204 3 e-53 NM009096 downregulated
b same as clone 4a________________
-c same as clone 4a
mRNA ribosomal protein S6 (Rsp6) 204 2 e-50 NM009096
a li d embryo cDNA 204 2 e-50 AK012284
9 10/11d embryo cDNA 204 2 e-50 AK013333 downregulated
b same as clone 9a________________
c no homology
Adult male tongue cDNA 432 e-121 AK009322
a Homo sapiens TATA box binding protein (TBP)-assoc. 96 7 e-20 NM003187
24 factor, RNA polymerase 11, G, 32kDa (TAF2G) downregulated
Human transcriptional activation factor TAFII32 mRNA 96 7 e-20 HSU21858
b not available
c not available _________
a no homology _______
25 b not available upregulated
c not available
Similar to transmembrane 7 superfamily member 1 121 4 e-25 BC003212
a Transmembrane 7 superfamily member 1 (Tm7sf1) 121 4 e-25 NM031999
27 Putative 7 pass transmembrane protein (Tm7sf1)mRNA 121 4 e-25 AF154337 upregulated
b same as 27a
c not available
a 1 Od old male pancreas cDNA 363 3 e-98 AK007336
28 T-cell receptor alpha locus BAC clone 137 3 e-30 AF259072 upregulated
b not available
c not available ____________ ________
a not able to edit sequence ____________
30 b no homology ________________ downregulated
c Human chr 16 BAG clone AG002044 ________
Table 1. Primary nucleotide BLAST results. Continued on next page.
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BAND CLONE PRIMARY BLAST SCORE e VALUE ACCESSION No UPREGULATED/
No. DOWNREGULATED
a Cctb gene for chaperonin containing TCP-1 beta subunit 210 1 e-54 AB022156
94kb genomic sequence encoding Tsx gene 198 2 e-48 MMTSXDNA
Endobrevin (Vamp8) gene-exon1 196 9 e-48 AF247193
32 b Non-receptor tyrosine kinase, Tyk2 gene 196 9 e-48 AF052607 downregulated
GTF21RD1 and CYLN2 genes 194 4 e-47 AF289667
c not able to edit sequence
a Embryonic stem cells cDNA 89.7 3 e-15 AK010304
34 b not able to edit sequence downregulated
c not available
94kb genomic sequence encoding Tsx gene 204 3 e-50 MMTSXDNA
a Endobrevin (Vamp8) gene-exon1 202 1 e-49 AF247193
35 Non-receptor tyrosine kinase, Tyk2 gene 202 1 e-49 AF052607 downregulated
GTF21RD1 and CYLN2 genes 200 5 e-49 AF289667
b 18d embryo cDNA 446 e-123 AK003980
c not able to edit sequence
a 11d embryo cDNA 341 2 e-91 AK019206
39 b not available downregulated
c not available
a 18d embryo cDNA 367 2 e-99 AK003443
Adult male hippocampus cDNA 361 1 e-97 AK013513
40 b Myeloid ecotropic viral integration site-related gene Mrg1 305 8 e-81 NM010825.1 upregulated
mRNA for homeodomain protein Meis2d 305 8 e-81 MMU57343
c 18d embryo cDNA 276 6 e-72 AK003443
Adult male hippocampus cDNA 270 4 e-70 AK013513
a Protein kinase inhibitor, gamma (Pkig) 333 8 e-89 MMU97170
47 Adenosine deaminase (ADA) gene 333 8 e-89 MMU73107 upregulated
b same as 47a
c not available
Table 1. Primary Nucleotide Blast. Description on next page.
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Table 1. Primary nucleotide BLAST results. The three clones from each band were
denoted a, b and c. This table includes the known gene sequences and cDNA sequences
obtained from homology searches. Score and e-values are also presented. A score is
obtained from a local alignment without gaps of a pair of equal length segments, one
from each of the two sequences being compared. A modification of the Smith-Waterman
or Sellers algorithms finds all segment pairs whose scores can not be improved by
extension or trimming. These are called high-scoring segment pairs or HSP scores.
Because HSP scores tend to be higher if the alignments are longer, the e-value becomes
necessary for statistical significance. The e-value is the probability of finding another
homologous sequence with a higher score. Therefore, the smaller the e-value the more
significant the results become. The accession number for GenBank of the known genes
and cDNA sequences found are also shown. Sequences obtained from band 44 were did
not give significant homology to any sequence in GenBank and therefore, were not
included in this table. The actual sequences can be found in the Appendix.
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BAND/ PRIMARY BLAST SECONDARY BLAST SCORE e ACCESSION
CLONE VALUE No.
4a 10/11d embryo cDNA (AK013333) Ribosomal protein S6 (Rps6), mRNA 1584 0.0 NM009096
11 d embryo cDNA (AK012284)
9a 10/11d embryo cDNA (AK013333) Same as 4a 1584 0.0 NM009096
11d embryo cDNA (AK012284)
24a Adult male tongue cDNA (AK009322) Human transcriptional activation factor TAFII32 846 0.0 HSU21858
mRNA
Rattus norvegicus neuronal cell death related gene 309 6 e-84 RNU40188
28a 10d old male pancreas cDNA (AK007336) Homo sapiens HSPC033, mRNA 454 e-125 AF092138
Homo sapiens 12kDa signal peptidase subunit, 450 e-124 HUMSP1S
mRNA
34a Embryonic stem cells cDNA (AK010304) no homology
35b 18d embryo cDNA (AK003980) no homology
39a 11d embryo cDNA (AK019206) WSB-1, mRNA 2488 0.0 NM019653
18d embryo cDNA (AK003443) Bos taurus smallest subunit (6.4kDa) of ubiquinol 172 4 e-43 D55637
cytochrome c reductase
40a Homo sapiens smallest subunit (6.4kDa) of ubiquinol 133 3 e-31 D55636
cytochrome c reductase
Adult male hippocampus cDNA (AK013513) same as 40a
40c same as 40a
Table 2. Secondary Blast. Some of the sequences from Table 1 that had significant alignment with a cDNA sequence were
submitted to GenBank for a search of sequence homology (Secondary Blast). The results are presented in this table as well as
scores and e values. A score is obtained from a local alignment without gaps of a pair of equal length segments, one from each of
the two sequences being compared. A modification of the Smith-Waterman or Sellers algorithms finds all segment pairs whose
scores can not be improved by extension or trimming. These are called high-scoring segment pairs or HSP scores. Because HSP
scores tend to be higher if the alignments are longer, the e-value becomes necessary for statistical significance. The e-value is the
probability of finding another homologous sequence with a higher score. Therefore, the smaller the e-value the more significant
the results become. The accession number for GenBank of the known genes and cDNA sequences found are also shown. It is
important to point out that the two genes characterized for this study were obtained from this secondary blast: WSB1 and SPC 12.
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BAND/ SECONDARY BLAST PROTEIN BLAST SCORE e ACCESSION
VALUE No.
CLONE
32a not available Rattus norvegicus Hermansky-Pudlak syndrome 54.7 2 e-07 AF333327
protein variant
Rattus norvegicus ubiquitin ligase Nedd4 46.6 5 e-05 S70642
32b not available Neprilysin-like peptidase gamma 58.2 2 e-08 AF302077
Tyrosine protein kinase Jak-3 47 3 e-05 Q62137
Embryonic stem cells cDNA (AK010304) Homo sapiens hypothetical protein FLJ21148 666 0.0 NP_079136
34a Saccharomyces cerevisiae transcription 89.4 e 3-17 NP_010543
regulator, Rms1p
35a not available same as 32b
35b 18d embryo cDNA (AK003980) no homology
Table 3. Protein Blast. Some sequences were submitted to GenBank for a search of homology using a protein database.
GenBank translates the submitted nucleotide sequence and searches for significant alignments with already existent
translated sequences. Sequences from bands/clones 32a, 32b and 35a were submitted for this search due to the arbitrary
results obtained from the previous blasts. Sequences with no significant sequence homology after the secondary blast (34a
and 35b) were also submitted to GenBank to search for homology with conserved protein domains. The results for this
Blast are shown in this table as well as scores and e values. A score is obtained from a local alignment without gaps of a
pair of equal length segments, one from each of the two sequences being compared. A modification of the Smith-Waterman
or Sellers algorithms finds all segment pairs whose scores can not be improved by extension or trimming. These are called
high-scoring segment pairs or HSP scores. Because HSP scores tend to be higher if the alignments are longer, the e-value
becomes necessary for statistical significance. The e-value is the probability of finding another homologous sequence with
a higher score. Therefore, the smaller the e-value the more significant the results become. The accession number for
GenBank of the proteins and putative proteins obtained from this search is also shown.
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3. Semiquantitative RT-PCR.
Two bands were selected for characterization: 28, corresponding to SPC12 the
smallest subunit (12kDa) of mammalian signal peptidase, and 39, corresponding to
WSB 1 (a member of the SOCS family of negative regulators). For alignments refer to
Appendix B and Appendix C.
In order to confirm the upregulation or downregulation of these two bands seen in
the DD gel, semiquantitative RT-PCR was performed using the same cDNA obtained
from the initial RT-PCR reaction. The results of semiquantitative PCR done on WSB 1
and SPC12 are shown in Figure 4 and Figure 5, respectively. WSB1 was downregulated
after induction with Edn3 which confirmed the results from the DD gel. However, after
semiquantitative RT-PCR the opposite effect was seen for SPC12. In the DD gel, the
band corresponding to SPC12 (28) is upregulated but appeared to be downregulated after
subjected to semiquantitative RT-PCR.
4. Characterization of WSBI and SPC12 using whole-mount in-situ hybridization.
Whole mount in-situ hybridization was the technique used to characterize the
expression patterns of WSB1 and SPC12. For comparison purposes, the expression
pattern of WSB2 (another WD-40/SOCS protein) was also analyzed. In order to make the
probes, ESTs containing a partial sequence of these genes were selected. All ESTs were
obtained from mouse embryonic libraries and were cloned into vectors containing
binding sites for the RNA polymerases adequate for riboprobe synthesis (T7, T3 and
SP6). Expression analyses of WSB1, WSB2 and SPC12 on whole-mount hybridized
embryos at different stages of murine embryonic development are presented here.
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NI I NI Figure 4. Semi-
quantitative PCR of
WSB1. cDNA from
induced (I) and non
induced (NI) cultures were
subjected to PCR using
WSB-1 and HPRTg
specific primers. HPRTg
(a house keeping gene)
was used as control
comparison. The ratio of
WSB-1 HPRTg cDNA used was 8 (I) : I(NI).
[ NI I NI
Figure 5. Semi-quantitative
PCR of SPC12 cDNA from
induced (I) and non induced
(NI) cultures were subjected
to PCR using SPC12 and
HPRTg specific primers.
HPRTg (a house keeping
gene) was used as control
comparison. The ratio of
cDNA used was 8 (I): 1 (NI).
SPC12 HPRTg
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" WSB1 expression pattern.
At 9.5dpc (Fig. 6A, B, C), WSB1 was highly expressed in the notochord as well
as in the nephric duct. It was also expressed in the forebrain, hindbrain, migrating cranial
neural crest cells and forming cranial ganglia. At 11.5 dpc (Fig. 6D, E), it continued to
be expressed in the hindbrain and also in the dorsal root ganglia and in the apical region
of the developing limb buds. Cross-sections of 11.5dpc embryos hybridized with the
WSB 1 probe revealed that it is also expressed in the lateral aspect of the neural tube and
confirmed expression in the dorsal root ganglia (Fig. 6G, H). It was also expressed in the
genital ridge (which gives rise to the gonads), and in the limb buds (Fig. 6I).
At 12.5dpc (Fig. 6F), WSB1 appears to be downregulated since the hybridization
signal was not as strong as in the previous stages. However, it still shows low levels of
expression in the dorsal root ganglia as well as in the developing brain and limb buds.
WSB2 expression pattern was analyzed for comparison purposes. At 11.5dpc
(Fig. 7A), it was highly expressed in the somites and the limb buds as well as in the brain.
At 12.5dpc (Fig. 7B), WSB2 continued to be expressed in the same structures.
* SPC12 expression pattern.
At 11.5dpc (Fig. 8A), SPC 12 was found to be expressed in the neural tube, in the
dorsal root ganglia, in the forebrain and in the developing cartilage of the trunk. SPC12
was highly expressed in the limb buds as well as in the eye, and showed a peculiar pattern
of expression in the liver. Cryosectioning allowed us to obtain cross sections of these
whole-mount embryos. Sections of 11.5dpc (Fig. 8C, D) confirmed SPC12 expression in
the eye, specifically in the lens, the iris and in the ciliary body. Sections through the
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Figure 6. WSB1 expression pattern. Whole-mount in-situ hybridization of 9.5dpc
(A, B, C), 11.5dpc (D, E) and 12.5dpc (F) embryos. Cross-sections (30um) of 11.5dpc
whole-mount embryos (G, H, I). fb: forebrain, hb: hindbrain, cnc: cranial neural crest,
lba: first branchial arch, n: notochord, nd: nephric duct, lb: limb bud, drg: dorsal root
ganglia, lm: lateral mesenchyme, nt: neural tube, gr: genital ridge.
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Figure 7. WSB2 expression pattern. Whole-mount in-situ hybridization of
11.dpc (A) and 12.5dpc (B) embryos. lb: limb buds, s: somites.
trunk confirmed expression in the dorsal aspect of the neural well as in the dorsal root
ganglia.
At 12.5dpc (Fig. 8B), SPC12 expression continued to be present in the neural
tube, in the adjacent dorsal root ganglia, in the forebrain, in the liver and in the eye.
SPC 12 continued to be highly expressed in the limb buds and at this stage, began to be
expressed in the hair follicles of the face.
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ph 11.5 dpc 11.5 dpi
Figure 8. SPC12 expression pattern. Whole-mount in-situ
hybridization of 11.5dpc (A) and 12.5dpc (B) embryos. lb: limb buds, Iv:
liver, s: somites, drg: dorsal root ganglia, hf: hair follicles, 1: lens, i: iris,
nt: neural tube.
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V. DISCUSSION
From the initial 30 bands selected for analysis, 11 showed significant sequence
homology to previously identified gene sequences (Table 1). The first two genes
identified in the course of this study were WSB 1 and SPC 12 and therefore, selected for
expression pattern studies. Using whole-mount in-situ hybridization, the expression of
both genes was analyzed at different stages of murine development. The results from this
analysis can be found in the previous section (see Results).
1. WSB1: A member of the SOCS family of negative regulators.
Band 39 was among the first ones to be sequenced. When blasted, it showed
100% homology to a complete cDNA sequence obtained from an 11.5d embryonic
library (AN: AK019206). When this sequence was submitted again for a secondary blast,
it was found to be 100% homologous to the sequence coding for mouse WSB1 (AN:
NM019653). The original sequence obtained from band 39 was found to be homologous
to the UTR (untranslated region) of the WSB1 gene and therefore not included in the
mRNA sequence of the gene.
A review of the literature available on this gene revealed that WSB 1 is a member
of the family of SOCS (suppressors of cytokine signaling) proteins. The recently
identified family members share a denominated SOCS box carboxy-terminal to distinct
domains characteristic of each subfamily. While the original SOCS proteins contain SH2
domains, WSB1 and WSB2 contain WD-40 repeats amino-terminal to the SOCS box.
" SOCS: Suppressors of cytokine signaling.
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Edn3 can also be classified as a cytokine because it is a protein that informs the
cell about its surrounding environment. The kind of signal they convey and the specific
cell response obtained depend on the type of cell targeted as well as the biological
process in which they are involved (Nicola, 1994). Cytokines are known to control
processes such as proliferation, growth, differentiation, immune and hematopoietic
responses, as well as anti-apoptotic signals (Leonard, 1999). Extensive research on their
mode of action led to the finding of a family of tyrosine kinases involved in many
signaling pathways induced by cytokines. The Janus family of tyrosine kinases (Jak
kinases) and signal transducers and activators of transcription (STATs) were among the
first to be identified as active entities of a transducing pathway from the cell surface to
the nucleus.
Jak kinases were physically associated to cytokine receptors when Withuhn et al.
(1993) and Argetsinger et al. (1993) demonstrated there was an interaction between Jak27
and the erythropoietin and growth hormone receptors, respectively. The binding of their
respective cytokine to these receptors induces receptor dimerization or oligomerization
resulting in a juxtaposition of associated Jaks. These cross-phosphorylate causing
enzymatic activation and in turn phosphorylate the receptor at multiple residues of its
cytoplasmic domain (reviewed by Darnell, 1997). This creates docking sites for STATs
(containing an SH2 binding domain) which are phosphorylated by active Jaks. STATs
subsequently dimerize and are translocated to the nucleus where they activate the
transcription of their target genes (reviewed by Imada, K. and Leonard, W.J., 2000).
It is important to note that four mammalian Jak kinases have been identified: Jakl, Jak2, Jak3 and Tyk2
(Horvath and Darnell, 1997; Leonard and O'Shea, 1998). Interestingly, Jak3 and Tyk2 were identified
during the course of this study (see BLAST results Table 1, 2 and 3).
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Although it is broadly accepted that cytokine signaling involves associated
kinases, it is also well known that the signal they convey needs to be regulated in
magnitude and duration (Krebs and Hilton, 2000). This is when the need for negative
regulators, such as SOCS proteins (suppressors of cytokine signaling), becomes critical.
The first member of the SOCS family of negative regulators to be identified was CIS
(now called CIS 1), for cytokine-inducible SH2 containing protein (Yoshimura et al.,
2000). It was found to be an early downstream gene of IL-2, IL-3, and EPO signaling
(Yoshimura et al., 2000). The second family member, SOCS 1, was identified by three
groups. The first group cloned it as an inhibitor of IL-6 signaling in the myeloid leukemia
cell line M1 and gave it the name of suppressor of cytokine signaling: SOCS (Starr et al.,
1997). The second group identified it as an SH2 containing protein that binds Jak kinases
and named it JAB for Jak-binding protein (Endo et al., 1997); and Naka et al., identified
it using an antibody that recognized the SH2 binding domain of STAT3 to look for novel
STAT familiy members. However, they found that the novel member was nothing else
but, SOCS1. They called it SSI-1 for STAT-induced STAT-inhibitor.
CIS and SOCS 1 transcription is rapidly induced after exposure to a range of
cytokines and both of them can inhibit cytokine signaling capabilities but in different
ways. CIS competes with STAT for docking sites in the receptor (Yoshimura et al.,
1995) whereas SOCS 1 binds to JAK kinases inhibiting their catalytic activity (Endo et
al., 1997; Yasukawa et al., 1999).
A study conducted by Hilton et al. (1998) in which the predicted amino acid
sequence of SOCS 1 was submitted for homology to databases revealed that there were as
many as six other proteins that contained and SH2 binding domain (SOCS2 to SOCS7)
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and as many as twenty that shared a conserved 40-amino-acid carboxyl-terminal
denominated, the SOCS box. Despite their common denominator, these twenty novel
proteins were divided into five structural classes according to the domains they exhibit
upstream of the SOCS box. The SOCS family (SOCS1 to SOCS7; CIS) contains an SH2
binding domain; the other proteins contain instead ankyrin repeats (ASB 1 to ASB4),
SPRY domains (SSB1 to SSB3), GTPase-like domains, or WD-40 motifs. Two proteins
containing WD-40 repeats have been identified: WSB1 and WSB2 (Hilton et al., 1998).
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Figure 9. SOCS proteins. Diagram representing the twenty novel proteins
identified which contain a common SOCS box (yellow). Green bars indicated
SH2 domains, blue bars indicate WD-40 repeats, pink bars indicate ankyrin
repeats, peach indicates SPRY domains and red indicates GTPase domains (from
Hilton et al., 1998).
Although the SOCS box is conserved in all family members, research on its
functionality is still underway. Early studies suggested that it is dispensable for the
inhibitory activity of SOCS1 and SOCS3 (Nicholson et al., 1999; Narazaki et al., 1998).
Other studies suggest that it is an active part in protein turnover in all family members
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(reviewed by Alexander et al., 1999). It has recently been suggested that the SOCS box
interacts with elongins B and C because of their sequence similarity to regions of the von
Hippel-Lindau tumor suppressor protein and elongin A, both of which bind to elongins B
and C (Kamura et al., 1998; Zhang et al., 1999). However, Kamura et al. propose that the
interaction with elongins extends SOCS protein half-life. On the other hand, since
elongin B has a ubiquitin-like sequence able to interact with proteasomal proteins and
since CIS has been shown to be ubiquitinated and sensitive to proteasomal degradation
(Verdier et al., 1998), Zhang et al. (1999) suggest that SOCS proteins interact with bound
molecules and direct them towards proteasomal degradation. It has also been shown that
cytokine receptors, Jak kinases and STATs remain very active in the presence of
proteasomal inhibitors (Verdier et al., 1998; Yu and Burakoff, 1997). The idea that
SOCS proteins might negatively regulate cytokine signaling by targeting these molecules
for degradation seems possible although it would also mean that deletion of the SOCS
box would cause cells to be extremely sensitive to cytokine signaling (Alexander et al.,
1999). Unfortunately, this concept does not correlate with previous findings that the
SOCS box is indeed not essential for the proper biological activity of SOCS proteins (see
above).
" WSB1 and WSB2
WSB1 and WSB2 were identified as members of the SOCS family of proteins
after a study revealed that they also contain (together with other 18 proteins) the
conserved 40-amino-acid carboxyl-terminal sequence denominated, SOCS box (Hilton et
al., 1998). WSB1 and WSB2 differ from the original SOCS proteins in the domain they
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exhibit amino-terminal to the SOCS box. WSB1 and WSB2 contain WD-40 repeats
upstream of the SOCS box, whereas other SOCS proteins contain SH2 binding domains,
ankyrin repeats, SPRY domains or GTPase-like domains.
WD-40 repeats are conserved core units that usually end with Trp-Asp (WD) and
were first identified in P-subunits of heterotrimeric GTP-binding proteins. WD-40
domains contain a region of variable length followed by a residue core of somewhat
constant length (40 amino acids) which is flanked by two characteristic pattern elements,
GH (Gly-His) and WD (reviewed by Neer et al., 1994). Analysis of the structure of
human WSB 1 allowed the identification of eight WD-40 repeats (Kehrer-Sawatzki et al.,
1999). However, WD-proteins do not have a common function. Some of the already
identified proteins containing this motif have functions that range from playing a role in
signal transduction to RNA splicing (Neer et al., 1999). Therefore, the function of WSB1
cannot be specified based on its WD structure.
Human WSB1 has also been identified, mapped to chromosome 17, and found to
be close to the neurofibromatosis type 1 locus (Kehrer-Sawatzki et al., 1999).
Additionally, an avian homolog of WSB 1 has also been identified: Swip 1. Studies of
Swipi have revealed that its expression is regulated by Sonic Hedgehog (Shh) signaling
in the developing somites and in the developing limb buds (Vasiliauskas et al., 1999).
Swipi was also found to be expressed in the dorsal and ventral aspects of the neural tube,
in the notochord, in the intermediate mesoderm (which gives rise to the urogenital
system) at stage 10 (equivalent to the mouse 9.5dpc stage), and later on found to have
strong expression in the branchial arches (stage 20). From stage 18 through stage 28,
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Swipi showed expression in the limb buds; and, from stage 20 through 29 it was found to
be expressed in the gut (Vasiliauskas et al., 1999).
Analysis of the expression pattern of WSB 1 and WSB2 has revealed that they are
expressed by certain neural crest derived cells as well as other non-neural crest
derivatives. At 9.5dpc, WSB 1 was expressed in the migrating cranial neural crest but
also, in the developing brain, the nephric duct, the developing limb buds (apical region)
and in the notochord. At 11.5dpc, WSB 1 continued to be expressed in these same
structures (with the exception of the notochord and the nephric duct) as well as in the
lateral aspect of the neural tube and the adjacent dorsal root ganglia. At 12.5dpc, WSB1
appeared to be downregulated but was still expressed at low levels in the dorsal root
ganglia and the developing brain. Analysis of the expression of WSB2 revealed that it is
expressed in the somites, the developing limb buds, and the brain from 11.5dpc through
12.5dpc.
Neither WSBI expression nor WSB2 expression alone shows the same pattern as
Swipi. However, if both patterns are combined, the resulting pattern is very similar to
that of Swipi. This suggests that murine WSBI and WSB2 might have diverged from the
primitive avian Swip] during a duplication event.
" WSB1 as a downstream target of Edn3 signaling.
Comparison of the expression patterns of WSBI and EdnrB show partial overlap.
WSBI and EdnrB are both expressed in some neural crest derivatives such as the cranial
crest (9.5dpc) and the dorsal root ganglia (11.5-12.5dpc). This overlap suggests that if
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WSBI expression is, indeed, downregulated by Edn3 signaling, this regulation might take
place in the cells that form the structures in which WSBI and EdnrB expression overlap.
In addition, because WSB 1 has been shown to bind Elongin BC (Kamura et al., 1998)
and a module composed of a member of the cullin family (Cul5) and a RING-H2 finger
protein (Rbx 1) to reconstitute potential ubiquitin ligases (Kamura et al., 2001),
downregulation of WSBI following Edn3 signaling might prevent ubiquitination8 of key
proteins, such as pkC and MAP kinase, that act downstream of the Edn3/EdnrB signaling
pathway.
Certain cullin family members have been shown to associate with other proteins,
such as Skp1, to also form ubiquitin ligase complexes. The complex formed by
Skpl/Cull/F-box (SCF-like ubiquitin ligase) has been found to continuously degrade p-
catenin in the cytoplasm, which is found downstream of the Wnt/Frizzled signaling
pathway (Latres et al., 1999). p-catenin has been identified as a transcription factor and
also functions as a tumor suppressor. Mutations affecting members of the Wnt/Frizzled
signaling pathway lead to an abnormal increase of 3-catenin activity which, in turn, leads
to the activation of genes involved in cell division (Gilbert, 2000). Because WSB 1 binds
a member of the cullin family and has ubiquitin ligase activity, it might be possible that
its assembly with these proteins leads to the degradation of certain transcription factors
that activate genes involved in cell proliferation, as in the case of SCF and p-catenin.
Therefore, if Edn3 downregulates the expression of WSBI, the ubiquitin ligase activity of
8 Ubiquitin ligases (E3) play a role in ubiquitination (targeting of proteins for degradation) by facilitating
the formation of isopeptide bonds between the carboxyl-terminus of ubiquitin and lysine residues in the
target protein or on the last ubiquitin of a protein-bound multiubiquitin chain. Proteins linked to
multiubiquitin chains are potent signals for proteosomal degradation (reviewed by Ciechanover, 1998).
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the complex formed by WSB1/Cul5/ElonginBC can be potentially decreased, preventing
the degradation of transcription factors that activate genes involved in cell proliferation.
2. SPC12: The smallest subunit (12kD) of the signal peptidase complex.
When the sequence of band 28 from the differential display was blasted, it was
found to be highly homologous to a cDNA sequence obtained from the pancreas of a 10
day old male mouse (AN: AK0077336). A subsequent blast of this sequence gave us no
significant homology to any other nucleotide sequences from GenBank. However, a
translated blast against the protein database of GenBank gave high homology to the
smallest subunit (12kDa) of the signal peptidase complex (see Table 1). Little
information is available on signal peptidases and it was only recently that the 12-kDa
subunit of the mammalian signal peptidase complex was cloned (Kalies and Hartmann,
1996).
Signal peptidases generally cleave off signal sequences of secretory and
membrane proteins in the lumen of the endoplasmic reticulum (ER), during protein
translocation across the membrane of the ER (reviewed by von Heijne, 1994). However,
the signal peptidase complex is possibly also involved in other proteolytic events in the
ER membrane such as further digesting cleaved signal peptides (Lyko et al., 1995) or
degrading membrane proteins in yeast (Mullins et al., 1995).
Mammalian signal peptidase was purified from canine pancreas microsomes as a
complex of five polypeptide subunits: SPC25, SPC22/23, SPC21, SPC18 and SPC12
(Evans et al., 1986). SPC 18, SPC21 and SPC 22/23 are single-spanning membrane
proteins that have the majority of their domains in the lumen of the ER (Shelness et al.,
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1993) and are similar in sequence to leader peptidase (van Dijl et al., 1992), the enzyme
that cleaves signal sequences during translocation of proteins across the plasma
membrane in bacteria (Zwizinski and Wickner, 1980). As a result, these polypeptides are
thought to also play a catalytic role in cleavage of signal peptides in eukaryotes.
Conversely, SPC 12 and SPC25 were found to span the membrane twice and to be largely
exposed to the cytosolic compartment with very few amino acid residues in the lumen of
the ER (Kalies and Hartmann, 1996). Since the active site of the signal peptidase
complex is in the lumen, it is improbable that SPC12 and SPC25 take part in the catalytic
activity of the enzyme. Furthermore, studies done on yeast have shown that Spclp (yeast
homolog of SPC 12) is non essential for proteolytic cleavage of certain precursor proteins
or for the degradation of proteins (Fang et al., 1996). It has also been found that yeast
mutants lacking Spclp and Spc2p (homolog of SPC25) are able to grow relatively well
when compared to wild type yeast, suggesting that the signal peptidase complex can still
be active in the absence of two of its subunits (Mullins et al., 1996). However, Spclp
does seem to be important for efficient signal peptidase activity (Fang et al., 1996).
It has also been shown that Sec1 ip (homologous to SPC18 and SPC21) is
essential for cell viability (Bohni et al., 1988) and cleavage of tested precursor proteins
(Mullins et al., 1995), suggesting that it contains the catalytic site. A study using Sec] ]p
mutants (sec1], temperature sensitive allele) revealed that when they are exposed to high
temperatures, they rapidly accumulate precursors of secretory proteins and stop growing
(Bohni et al., 1988). A more recent study showed that overexpression of Spclp
suppressed the sec] temperature-sensitive phenotype and increased the amount of
precursor proteins cleavage found in the sec] mutant, whereas depletion of Spclp
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exacerbated the secl] defect (Fang et al., 1996), suggesting that it might play a role in the
efficiency of the complex.
There is no more information about the function of yeast Spclp or mammalian
SPC12. Being part of such a ubiquitous complex, it was surprising to find that SPC12
has a restricted expression pattern during development. Because it has been shown that
SPC 12 is not part of the active site of the signal peptidase, it might be possible that it has
an alternative function during embryonic development. Due to the scarce information on
this specific subunit, one can only speculate that if SPC 12 is indeed involved in post-
translational modifications, it might play a role in the cleavage of precursor proteins
whose transcription has been induced indirectly by the Edn3/EdnrB pathway.
3. Concluding Remarks
The role that the two genes characterized in this study play during development is yet
to be established. Both of them were found to be expressed by neural crest derived cells
which suggests that they might play a part in the development of these cells. However,
subsequent functional studies, such as a knock-out, might help us identify those cell
lineages whose proper differentiation depends upon the function of WSB1 or SPC12. In
the case of WSB1, because of its ubiquitin ligase activity, enzymology assays would help
identify the substrate targeted by the WSBl/Cul5/ElonginBC complex. In the case of
SPC 12 it would be interesting to analyze the expression patterns of the other subunits of
the signal peptidase. If the other subunits share the same expression pattern, then SPC 12
might be acting during development as part of the signal peptidase complex. If the
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expression patterns are not the same, then SPC 12 could be playing an alternate role
during the development of the cells expressing it.
It is important to note that the technique used in this study for identifying
differentially expressed genes, DD RT-PCR, is not completely accurate. Although, DD
RT-PCR is inexpensive, not difficult to carry out and yields plenty of information to be
analyzed, it can convey misleading artifacts. For example, band 28, which corresponded
to SPC 12, was shown to be upregulated after Edn3 induction in the DD gel. However,
after repeated trials of semiquantitative PCR, SPC 12 was shown to be downregulated
after Edn3 induction. Such contradictions lead to lay emphasis on the drawbacks of
selecting this technique for similar studies.
Although only two genes have been characterized for this study, the remaining
genes identified and listed in Tables 1, 2 and 3 are yet to be characterized.
Characterization of the latter is strongly suggested for ensuing projects as well as
functional studies of WSB1 and SPC 12. Characterizing the expression pattern and
uncovering the function of more genes found downstream of Edn3 signaling could
identify possible players in NCC development and eventually lead to the emergence of a
novel regulatory pathway.
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VIII. APPENDICES
APPENDIX A
Sequences from selected bands from the Differential Display gel.
4 clone a:
AAGCTTTTTTTTTTTCAAGGTCATTATTTATTTGTTGCTCTTAAAGACTCAT
TTTTGACTGGACTCAGACTTAGAAGTAGAAGCTCTCAGTGAGGACAGCCT
ACGTCTCTTGGCAATCAAGCTTA
clone b:
AAGCTTTTTTTTTTTCAAGGTCATTATTTATTTGTTGCTCTTAAAGACTCAT
TTTTGACTGGACTCAGACTTAGAAGTAGAAGCTCTCAGTGAGGACAGCCT
ACGTCTCTTGGCAATCAAGCTTA
clone c:
AAGCTTTTTTTTTTTCAAGGTCATTATTTATTTGTTGCTCTTAAAGACTCAT
TTTTGACTGGACTCAGACTTAGAAGTAGAAGCTCTCAGTGAGGACAGCCT
ACGTCTCTTGGCAATCAAGCTTA
9 clone a:
AAGCTTTTTTTTTTTCAAGGTCATTATTTATTTGTTGCTCTTAAAGACTCAT
TTTTGACTGGACTCAGACTTAGAAGTAGAAGCTCTCAGTGAGGACAGCCT
ACGTCTCTTGGCAATCAAGCTTATAACGCAGGAAAGAACATGNGAGCNA
clone b:
AAGCTTGATTGCCAAGAGACGTAGGCTGTCCTCACTGAGAGCTTCTACTT
CTAAGTCTGAGTCCAGTCAAAAATGAGTCTTTAAGAGCAACAAATAAATA
ATGACCTTGAAAAAAAAAAAGCTA
clone c:
AAGCTTTTTTTTTTTCATAAATCTCATCACTTTATTCGNTGGTGGGCAATCA
AGCTTANGCCG
27 clone a:
AAGCTTGCACCATCAACAGTTCAGAATGTTCTTATTAATCCATCGGTAATT
GGGTCCAAAAACATTCTTATTACTACTAATATGGTATCACAGAATACAGC
CGAGTCAGCAAATGCACTGAAACGGAAACGTGAAGACGATGATGATGAC
GATGATGACGATGATGATGATGACTATGATAATATGTAGTCTAGCCACGA
TGCATGTAACCTGTGTTCTTGGACTTGGATCCATTGTACTACAAGTTAAAA
62
AGCATGTTAGATGTTTTAAAGCTGTACTTTAGAAAGTGGTGTTTCATACGT
ATGCTTTGCTTTTTGATTAAAATGTTCAGTTTTACTAGAACTAGTGATGGT
TTTTCATCAACCTTTATGCACAAATAAAATTGTCATTTATCAGTTTGA
AAAAAAAAAAGCTTA
clone b: not available
clone c: not available
25 clone a:
AAGCTTTTACCGCCTAAATATCGTTTTGGTCAGTGAACTGCATATTACCAT
AAGATGGTAATGGAGCTGAAAAATTCCTGGGACCTAGCGAGGTCACAGCT
GTGATGATGTGTTTTACTCAGGTCTTGGTGCAAACAAGCCAGTGCATTGCC
AGTCTTGTAAAAATGTAGCACAATTGTGTACAGTACATACTTGATAGTGC
TAATAAATGGCTTACTGATCTATGTAAA AAAAAAAAGCTTA
clone b: not available
clone c: not available
27 clone a:
NTTTTNGAGCCCGAGTTNCTCNAGNCNCNACGTGTGCNATCTACATGCNT
GCTCGAGCGGCCGCCACTTGACTATAGANNCNATATNGAACCCTCTNTAN
GCNTGCTTACNGCNGCNNACACATTNNAAGNTANGGGGANNCATAGTAC
NNNGGGNTGTACCNANCATGCTCAATNNCAANANTTTNTNNNANACTCTG
NCCTAAGCCTGGCCCTTCTTNATCTGAAAGCACTACTACNAGCACTCCAT
NAACNANNGNATACTGTTANTANNTAGATGNTGACACTATTAAACCTCCT
CTGNTGTGTGGGTANNNAAAAAAAGCTTA
clone b:
CGCCCGANTNACTCCAGGCNCNACGTTGCNNTCTACATGCCTGCTCGAGG
CGGNCCCCACTNNCTATAGATANTATATAGAACCCTCTNTTAANCTTCTAC
CGCCNCTCANNCATTCCAAGTTANGGGGAANCATAGTACCANGGGCTGTA
CCNANCATGCTCANNCCAANATTTTGTNNNANACTCTGCCCTANGCCTGC
CCTTCTTCATCTGAAAGCACTACTACNNGCACTCCAGTGACNAAGGGATN
CTNGTAATAATNNAGNNGCTGCCACTTATAAANCCTCCTTTGCTGGGGGG
GTAAAAA AAAANGNTNAGGGGGAAATTCNAAANCCTTGNCGGCNGTTN
NTATNGAANCCAANCTCGNANCCANNNTTGNNGCNNACTTGGGGANTTT
NNTANGGGANCCNAANTANNTNGCCAAATTNANGGCNNNANTNGNTTCN
TNNGTNAAATGGCTNTCCGTTCCNATTCNACAAAGATNACAACCGGANCC
63
GCGTNGNGCTCACTGCCCGGTNTCCAATGGGGGAANCCTGNCGCCCAANT
TGGATTAANGAACCGNCNCCNTCCGGGGAGAGGNAATTTGCNTTTNGNGC
NCTTTNACGATTCTCCCACACTGACTNGATNGGCCTNGGNCNTTNNNGTG
NNTTATCCGTNTTNTCTCTCTNNAAAGNGGNNANNCGGTNTCCCNAAANC
GGGGGANNCCCNGAAAANANATGGGGGCT
28 clone a:
AAGCTTTTACCGCCTATGTTCTTATAGCACAGCTGTGTCGAGATCTAATTG
TCATGGCTTCATTTCTAATCCAAATGTATTTTAAGTTATGACTATTTTATAC
CATCTCTTCATAAGCTTGTTATGGAGAACAGGAGATACAAGTATGCAATG
CTTCTTTCCCGTGTGTATAATGAATAAACACTTCATAACTTGTAAAAAAAA
AAAGCTTACAGAATCAGGGGATAACGCNG
clone b: not available
clone c: not available
30 clone a: not able to edit
clone b:
AAGCTTTTTTTTTTTCAATGTGTTATAACAAATGGATGTTNGGCTCANGAG
CCCAGAACAGCCTCTCTATCAATCACAGCAGGCAGTTATCACATGGTAGG
CTCCAAGGAGGAACTGTGTGCGCCCCAAGTGTCTGATGGCTGGCTGTACT
TCTCTTCCAC
clone c:
AAGCTTTTTTTTTTTCAATGTGTTATAACAAATGGATGTTAGGCTCAGGAG
CCCAGAACAGCCTCTCTATCAATCACAGCAGGCAGTTATCACATGGTAGG
CTCCAAGGAGGAACTGTGTGCGCCCCAAGTGTCTGATGGCTGGCTGTACT
TCTCTTCCAC
32 clone a:
AAGCTTTGGTCAGGCAAGGGGGAAGTACTAGGAGCAGCCATTATACACTG
AGGTCAGAGGAGGGTGGCATAGCTGGTTGAGGTTGTGTTTGGAAAGGGCT
TAAGAAAGACTCTGAGGGGCTCAGGAGTTAAGAGCACTGACCGCTCTTCC
AGGGGTCCTGAGTTCAATTCCCAGTAACTACATGGTGGCTCACAGCCATC
TGTAATGGGATCTGATGCCCTCTTCTGGTGTGTCTGAAGACAGAGACAGT
GTATTCACGTACATGAAAAAAAAAAAGCTTA
64
clone b:
AAGCTTTTTTTTTTTCGAGACAGGGTTTCTCTGTGTAGCCCTGGCTGTCCA
GGAACTCACTTTGTAGACCAGGCTGTCCTCGAACTCANAAATCTGCCTGC
CTCTGTCTCCCAAGTGCTGGGATTAAAGGGNGGNGGGGGACACCTTTACT
AGACTTNCTTCTTATATATTTCATATCACAAATACNCCAGCTCCTTTATGG
NTTTATTCTATTTGGGAATTATAGAAGGGATTCTAGGNTTNAAAAACATA
ACAATGNGNATTGNAAAGCATAAAAAATGNTTAGACTCCTTAAACAGNC
NAAGCTTAANGGGGAAATTCANCACACTGGGGGGCGGTCTAANGGA
clone c: not able to edit
34 clone a:
GCCCGGTNCTCCAGNCNCNACGNTGCNNTCTANTGCCTGCTCGAGCGGCC
CGCCTNACTATAGANNNNAANNGACCCTCNCTATNCCTTCTCTCACGNAN
GGCNATTCCACCAAAGGTNGNNGNATCCTTGNNAAGAGTTTNNGCTATCC
TCGGGNTTTCGCCATNCCANATNAANTNNTTNGTACCACTTTTGGGATTA
NNTCTGGTTTGAGAGGANAGAAAANCTATTNCATGAGACNCTTTACTCCC
AATCCAAAAGCAGATGCTTGCANANGAACTCANTNCTACAAGATTCATAN
NNCTTACCCCCTANNTGCNCANATGGGNTCNAATNNNNACAAGAANCTN
AANNCTACCCNNNNAAAAANANANNTNNGGGCCAATTNCNANANNANG
GNGGNCNNTACCNTGGGAANCCAACNCNNTACCNAGCNTTNCNNCNNAC
TTGGGGANTNTANTAGGGGACCCCAACTNCGTGGCNNAATNANNGGCAN
AACTGGNTNCNNNGTGNAAGTGGCTTACNGTCNCAAGTNCACACAAGAT
ACCANCCGGNACCCTTAANAGNTAAGNCNCGGGTGCCTTATNANGGNAC
CTACCNACCTTAAANGNNTTGNGCTCAACCCCCGGTTTCCAATGGGGGAA
CCTNGCCNCCNAATTGGNTTANGGATCCNGNCCCCTCCNNGAAAAGGAA
NCTGGNGATCNGCGCNTTTACGGATCCTNCCNACCTNNNTNATAAGGCTN
NNTCCNTTTTGNTCNNNNATNCGGTTTCNCCCNCTCNN
clone b:
GCGCCCGAGTNACTCCAGGCNCNACGTTGCNNTCTACTGCCTGCTCGAGC
GGCCCCCACTNACTATAGATNCNATACAGAACCCTCNCTTAGCCTNCTCN
NNCCNGGNNGNNCTTACATNGGGGGNNGGAACTCACAANCTNAGNNNGC
TTCCTGANAACCTTTTAACAGTCATGTNCTGTNNCTTNCAAAGGANGCAA
ANTTGCTACTTCCNTATTTGGCATGATAATCAAATGAAAAATNACTAAAA
AGTNAANTTACATGTNTNCNCNTTTGGANTGNTGTCNACAAATTTATGAG
CATGCTATTTNNACTAATGCCNTCANANNTTNTTAGAACTTAATNAACAN
GNGCTGNNTTCAANTTTGANNNANNAAAANCTTANAGNCCAATTCAACA
CACTGNNNGNCGTTCTAGNGGATNCAAACTCTNNACCANGNNTGANGCA
TAACTNGAGTANTCTATAANGGCACCNAAACNCCTTGCCGNANTCATNGC
65
CATAGCTGNGTNCTGTNTNAAATTGNTTNCGCTCNCNATTCCACACANNA
TACAANCCGGAACCNTAAANAATNAANNCTGGGGGCCTATTCANNGAGC
TAACTCCNTTAATNGCNNTGGGCTCACTNCCCGNTTTCCAATNNGGGAAC
CCTGCCCNCCAANTGCATTAATGAATNCNGCCCCNNTCNNNGANAGGGA
NCTTGCNNNCCNGCNCTTTTCCGNTTCTNCNCCT
35 clone a:
AAGCTTCGACTGTTTATAGATAGTCTTAACATTTTTTATGCTTTGCAATAC
ACATTGTTATGATTCTGAAACCTAGAATACCTTCTATAAATCACAAATAG
AATAAAAACATAAAGGAGCTGGAGTATTTGTGATATGAAATATATAAGA
AGGAAGTCTAGTAAAGGTGTCCACCACCACCCTTTAATCCCAGCACTTGG
GAGACAGAGGCAGGCAGATTTCTGAGTTCGAGGACAGCCTGGTCTACAA
AGTGAGTTCCTGGACAGCCAGGGCTACACAGAGAAACCCTGTCTCGAAA
AAAAAAAAGCTTA
clone b:
AAGCTTTTTTTTTTTCAAATTGATTAATAAAATAGAAATTTTATTATACTTT
GCATATCCTTAAAAATATGAAAAACAAGGCCAAAAGTTTAAAAACAGTTT
TACAGATGTGCATGCTAACAATGGTTTAATACATTTCCAATTATATAAAAT
ACATTATATAAAAGATGCCTAGATTTTTACATACATCAAGTGAATTAAAT
AAAGCATTCATATATTTCTATGATCTAAGTGCAATATGCACATACGTAGA
AAAAAAATACTGATTTCCTGACCAAAGCTTA
clone c: not able to edit
36 clone a:
GCCCGGTTCTCAGGCNCNACGGTGCCNTCTAATGCNTGCTCGAGCGGCCG
CCACTGTNTATAGATANCTGCAGAANCCTCNCTTACCTTCTCTNACGGAC
NGCTGTNTAATAATATTAGGNNGAAGGNGACCNNTAGCTATTATNTTATA
TNANGAGAAAGTTCTTCTGANGATCATNGGTTATTACANNGATANNAAGT
TATCAGCANNTNAACCATATCTNATCTNACTTTATTGCTAGAGTTTATAGC
ATTACAGGATTTCTTATTANNTTATTTNGGNAGAGTGATATAATTTGTTTT
AAAACTGNGCCTTANCAATTGTTGAAAAAAAAAAAGCTTAANGGCGAAT
TCCAGCACACTGGCGGCCGTTACTAGTGGATCCGAGCTCGGTACCAAGCT
TGATGCATANCTTGAGTATTCTATAAGGGNACCNAAANAGNTTGGCGTAA
TCATGGCCATAGCTGGNTNCTGTGTGAAATTGNTANCCGCNCACGATTCC
ACACANNATACAANCCCGGACNNTAAAGNGTNAAGCCTGGGGTGCCTAA
TGAGTNAGCTNACTCCCTTAATTGCGNNGCGCTCACTGNCCGGTNTCCAA
TNGGGAAACCTGNCNCCNACTGNTTAANGNNTCNGCCNCCCNNCNNNGA
NAGGCNNCTGNNNNNCGGNCNNCNTTTNNGNNTCCTNNCTNNCTGNNTN
NNTGGC
66
clone b:
TGTTTGTGCCCGNTNCTNAGNCNCNACGGTGCCNTCTACTGCCTGCTCGA
GCGGCCGCCANTGCTATNGNTATCTGCAGAANCCTCNCTTAANCTTCTCN
CACGGACNGCTGTNTAATAATATTAGGNAAAAGGNGANCNGTAGCTATT
ATGNTATATNANGNGAAAGTTCTTCTGANGATCATNGGTTATTACANNGA
TANNAAGTTATCAGGANNTNAACCNTATCTTATCTCACTTTATTGCTAGAG
TTTATAGCATTACAGGATTTCTTATTAGNTTATTTNGGNAGAGTGATATAA
TTTGTTNNAAAACGGGCCTTANCANTTGTTGA AAAAAAAAAAGCTTAAGG
GCGAATTCCAANACACTGNGGCCGTTACTAGNGGATCCNAGCTCGNTACC
AAGCTTGANNGCATACTTGAGTATTCTATAANGGNACCNAAANNGCTTGG
CGTAATCATGGCCATAGCTGGNTNCTGTGTAGAAATTGCATNCGCTCNCN
ATNNCACNCAANATACAANCCCGGACCNTAAAGNGTAAAGCCTGGGGTG
CCTAATGAGTGANCTTACTNACATTAATTGCGNTGNGCTCACTGNCCGNT
TTCCANTGGGGAACCTNCNNCCNANTTGCTTNATGAATNNNGCCCNNNTN
CNGNGANAGGNNNCT
clone c: not available
39 clone a:
AAGCTTTGGTCAGGATAGATGGTGTGAAACTGATAAGAGGTTTTGGATGT
GAAAAAGAGTTTCCAAAAGAATGGTGTCTGGGAGTTTGAATGTGATGATT
AAAAAAAGAGCCAAGGAAAAAGGTAGCTAGAAAAAAAGGTTGGCTCTCA
TCAGCCTTAATTTTGGAAAGCAGCTACTTACCCCTCAGAGAATAAAGTAT
TATGCATTCTTGTCAATTTGAAAAAAAAAAAGCTTA
clone b: not available
clone c: not available
40 clone a:
AAGCTTTTTTTTTTTCCAAGGCATAAGAATAAGGTTTAATGCTGCACCCAT
CAAGGCAGCCCTAGTGTCTGTCAACATGGAAGCTCCCTGAGCGGTGCAGA
CCTCTCCAGTGTCCAGCTTCCTCAGTGTCTTCCACAGGACTACGCTGTGTC
TGAGGCCTCGGCACATGGTACCATCGAGGCCTGTGGTGGGGGAGGGGCT
clone b:
AAGCTTTTTTTTTTTCAATTGAGGTAAACACATAGAATATCTAACATGAAA
CAATTAAAAGACCGAACTCTGTACGAAGTTTGTTACAGTATTCTCTTGCTC
67
CTTTTTATCCCCCAAGCTTTGAGTTCCTGATAGAATCCTACTTATGGTGCA
ACGACCATGAATAACTTGTGTGTGTGTGTGTGTGTATGNGCGNNGANAAN
CTTA
clone c:
AAGCTTTTTTTTTTTCCAAGGCATAAGAATAAGGTTTAATGCTGCACCCAT
CAAGGCAGCCCTAGTGTCTGTCAACATGGAAGCTCCCTGAGCGGTGCAGA
CCTCTCCAGTGTCCAGCTTNCTCAGTGTCTTCCACAGGACTACNCTGTGNN
TGNNGCCTCGNCACATGGTACCATNNANNCCTGTGGNGG
44 clone a:
AAGCTTAGTAGGCAAAAAGACAAGTATCTGGAAACAAGAACACAGCGCC
TTAGAGTAAAGGAGGAAAGACTGGGACATCACCTGACTGTGGTTGNNNT
ACAGGNGA
clone b: not able to edit
clone c:
AAGCTTAGTAGGCAAAAAGACAAGTATCCGGAAACAAGAACACAGCGCC
TTAGAGTAAAGGAGGAAAGACTGGGACATCACCTGACTGTGGTTGTTTTA
CAGGGGATCTTCAGAGCTGTTGAGATCATTAAAGCATTAAACCTGCATTG
TAGGTTGNTAACTGATTTTTCATAACACGCTTCAATGCTTTTACTAATCCT
AGTAATTGTTAATGNCACTTGNGAAGATGNACAATTNCAGTANNTNATNT
TANATATTTANATTATTANACCTTTTATATTANNTG
47 clone a:
AAGCTTGCACCATGAGATGTTATTTATTCAGCTAGGCGGGGCTCGAGCCA
GGCCCTGCCCCTAGGTGAGCAGCCGCCACCTGGACAGGGACTGTCCTGTC
ACCACTCACCCTCCAGCCAGCCTGTCTGTCAGGAAGATCTTCCTAGCCCTT
TTTTAAAGCCTCTTTTACATTTTTTAAAAACATAACTTTTTCAGAGAGAGA
GGGGAGCTGACAATCACTTTTCTTCTGTTTTGGTTTTTGGTTTTGGTTTTGT
TTTGAAAGCCGTTTAAAGCTCAGTTCTGATGATCTATGCAGCTCTAAGTTT
CCTCATGGAGCCTCACAGATCCAGTTTTGGGAAAGGATTTGGACTCAAAA
CTAACTGACCAATTCTTTGCCCTTTGTACCAAGAGACTGATACTTANGCCC
AGGAAATAAATGCTGGTGGTTTGNGAAAA AAAAAAAGCTTA
clone b:
NAGNNTGNNCCNTTTGNAAAGGGGTACTNTTGGATTCCNGNTGGACNNA
AATCACNTGAATAAAAGNTCCNTNCTGGGNGCTNATTTGNGGGGGGGNG
GGCTNAAGTGTGTACCAAGAATTGGGTGGNGGNNACAGAGACACACCCC
68
CTCTNTGACACAACCCTCCTTTNCCCCGAAANTAAATGCGNGNNTTTATNT
AAAACNCAACNTTNTGTGGAGANCCANANAATAAATTTGTNAAACANAA
GNTTNCTGTGTGACCCCNGNAANGGGTATNCNATNNTATNTTTNTNGNAN
ACTGTGTGTCNTATATGGGAAAAAGNTCTCTAACCNNGTGTTTGTGGNGG
CNCCNCATGGGTAGAANATTNANACTGNTNCCCATTAAAANNTGAAGAA
CTTNTTGGTGNATGAAAAAAAANACNCCTCTTCTCAAAAAAAAAAANTTN
TTGGNGGATNTCTCCACCNNGTGGCGGNNCTAATTGGAGCCCCCTCCTNC
CCCNNTNTTGATAATTTGGNGANTTTNTTTGGCCCAAATNANTTGGNGGG
ANTATGTGTNNTTGTTNCTGGGGAAANTGTTNTCCNCTCCAATTCCCCANA
TACANCCGGAGNTAAAGNNNAANCNTGGG
clone c: not available
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Appendix B
Alignment: 10 day old male pancreas cDNA, SPC12, and 28.
* 20 40 * 60 * 80
10d ------- TRGGICIAIV"CGAIGBMIAAIIITCG4I TGMTIGGCCTTG®i0T9
S P C 1 2 TGGGCTTAIAAJGSCIFT.ST--ICGEQCGIR9AGTVSCAlAlCTTA000JBIAQ
28 --------------------------------------------------------------------------------------
g g c cggc a tga cgc gc g C ctc cg t a c c c c t
* 100 120 * 140 160
10d IATIGSITJIGTCSVT(TCITiVTIG'TAB GGTIETCAGyyASJiBvlall.RA
S P C 1 2 iGCITIICIJCCG®4CJCAFS.CiyClClCCIS--- jjCAGCjjGBIijj18j jiG
28 ------------------- -------------------------------------------------
a c gc ac cg t g tg c g tc Ct ca ccatgctgga ca c t g a g t c g c t g c c c a c c a g a t g g a t t a
180 200 220 240 2
10d lAnill§G®l1UgasAlinCi1V.SilssSiM.Bli!alflilGGJCATEIiiMy aliiallui
S P C 1 2 9isuu C s uaiG a18e7 si s s mQ QAA iTTA ra©l C L ^
28 -------- ----------------------- -------------------------------------- -
caaggg cagaa ctagctgaacagatgtttcaggg t tcttttttctgcaatagttgg tttatctacgggtacgtggctg
60 280 * 300 320 * 340
10d Ji1sTjaT1, u'1'gIii9, C21 lai.110111uIf 61 4.72di1 uIIiIC01CfB U
M. 1:9u f 11 e- C9u .... 'e .. u ser y r ni s c .0 1 !! i y : T'11 1 u^r eu 9u^Tu us la 161TjaAlev5a
ejj u aj160 WeTeb
28 ----------- ------------ ----------------------------------------------- -
aacagtt gggtggactgtcta atagttatggccggatttgcttt tc tgtttgctgacacttcctccatggcc atcta cgc
* 360 * 380 * 400 420
10d nT C 423
S P C 1 2 RG T9e Cia ujuuaJi3aa7aa1'641UiAaCjAu®iIs iC s aa : iC A 424
28 -------------------------------------------------------------------------------------- -
cg catcc ct aagtggttacctgttcaaga t a gcacaga gacaagaaa cagggga agaaaaattaagaggcatgctaa
440 460 480 * 500
10d
S P C 1 2 
DWIWIIM
28 ------------------------------------------------------------------------------------ A '-
aaataa tga g tttcatgattcagcacctgcttttgtttc tgtgagatgagct 
aattgctttcata c a a a gA
70
5 2 00 5 60 5 80 60 0
SPC12 :IIAT2IIAIIIIAICIIIII IIIIIIIIIIATIIITIGICIITITATA GC GT GG --- 588
28 : lIEITTIIIII-1IIhIllIUIEIIIIIIIUI IUS iIII IiI GT
GCTtaaACCgCCTA TGt= ZGC ACAGCTGTGTocAGATcTAaTTgTCaTgg CTTCATTTCTAatCCAaaTGtaTTTtaa
620 * 640 * 660 680
10d : iiaEaiahaIaasaaa'Eaih ahiiEEEhDG hII hiEhE ! EEUEE A
SPC12 :---------------------------------------- -------------------------------
28 :aDhiD!EmEE91 1 ih haEEEaEII hhEIhhIa I'A GTIGTCTCGiiihI tiEA
gttat gactat tttat accatctcttcat aagcttgttat gagagaacagagatacaagtat gca at gct tct t tcc cg tgtgtat
* 700 *720 * 740
10d iDE~iciiiaiEahhhl!Ei®IC------ --------------------------- 703
SPC12 ------- --------------------- -------- -------------------
28 : llAEflgji5flg iiAAAATAAAAAAAAAAAGCTTACAGAATCAGGGGATAACGCNG 233
aatga taaacacttcataaCttg
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APPENDIX C
Alignment: 39, 11d embryo cDNA and WSB1
* 20 40 60 80
39 -------------------------------------------------------------------------------------- -
11d CCAGGAACATTCGGCGGCGGAAGCATTGGCGGGCTGTGTGAGTCTGTGAGTGGAAGGCGC GC CGGCTCT TT TGTCT GAGTGTGACC 86
W S B 1 --------------------------------------------------------------------------------------
* 100 120 * 140 160
39 -------------------------------------------------------------------------------------- -
11d CGGTGGCTTTGTTCCAGGCATTCCGGTGAT TTCCT CC GGGCAGTCCGCAGAAGCCGCAGCGGCCGC CCGC GCTCTCTCTGCAGTCT 172
WSB1
180 200 * 220 240 * 2
39 ------------------------------ -------------------------------- -
11d CCACACCCGGGAGAGCCT GAGCCCGCGTCACGCCCCT CAGCCCCC GC TGAGTCC CTTCTCTGTTGTCGC GTCCGAATCGAG TTCCC 258
WSB1 - ------------- ------ --------
60 * 280 * 300 * 320 340
39 ---- ------ ------------------------- -- ------------------- -
11d GGAATCAGACGGTGCCCCATAG p 11" iIIIIZe diIIIIAnV.2i '
WSB1 ----_-_-____ ----- :p5 ppiL II1911ppl71i1674161iipZi1100 111
atggccagctttcccccgagggttaacgagaaagagatcgtgagatcacgtactataggggaac
* 360 380 * 400 420 '
39 ------------- ------ -------------------------------------------------- -
11d 82621 6. IS E." Q
W S B 1 p ppyl dJp' i Vi 'pp u'pppp i 'iiVii e 5 rup p 3616 ulh
tcttggctccagcagctccttttgacaagaaatgtggtggtgagaactggacggttgcttttgctcctgatggttcctactttgcg
440 460 * 480 500
39
ltd p ppi®ii ipipp®Sip: p4ii ppp p p94p p CsBi p ppppii i'
WSB1
tggtcacaaggatatcgcatagtgaagcttgtcccgtggtcccagtgccgtaagaac tttcttttgcatggttccaaaaatgttac
72
5 2 0 * 5 4 0 5 6 0 * 5 8 0 * 600
39 -------- 1----------- 1---/-------e------------1-----------------------------------------
11d i ii\1 J iii Lt 1r la iii lS iii Y i uu vu / 7i® J i1 -
WSB1 9,a i l i7 i 4 i ii il7iiii V i . dv wr l7i iiiii i ii:
caattcaagctgtctaaaattggcaagacaaaacagtaatggtggtcagaaaaacaagcctcctgagcacgttatagactgtggag
620 640 * 660 680
39 -------------------------------------------------------------------------------------- -
1 1 d a®QBQu©®BZEQ®©rllBllBBBB®Iuailliml©allamusaalal:lMalilialZ
WSB1 a a aEl I 'a M ®© U L I { u iu il L al a aaaaa a^ c'aul a ul C 'uC' 'WE 'Imutel@Kwgw
acatagtctggagtcttgcttttgggtcttcagttccagaaaaacagagtcgttgcgttaatatagaatggcatcggttccgattt
700 720 * 740 760
39 -------------------------------------------------------------------------------------- -
11d a Ca a© a L M ar f l M uu : ir allllaaa :al flr a© aaaaf l
W S B 1 a 7a ar au e 71 31 1 u a au +ilyl aaa aal B M G i9al iaaaac C.l GGGATGTATATACAGGAAAACTCCTCCTTAA
ggacaggatcagctactccttgccacaggattaaacaatggtcgcatcaaaatctgggatgtatatacaggaaaactcctccttaa
780 800 * 820 840 860
39 ------------ - ------------------------- ------------------- - -
11d
w SB1 " Glr r4li rirril iY iiiiiwr. ly i nr 'i i C7i Y {7 C1 .9 u r L7 iSi rer. Bibb Q.
tttggtagaccacattgaaatggttagagatttaacttttgctccagatgggagcttactccttgtatcagcttcaagagacaaaa
880 900 920 940
39 ---------------------------------------------------------------------------- ----- -
11d l 1 l aa sul uM!®® a ®® iaa r aM r u a ©u pQa:a aL r yu L J aaa u l {a L ©a 1r u
W S B 1 7 aa a'l u ua Y7 uaaa a ua aaaa®a©6 J iiViaa ©i LIV YL
ctctaagagtgtgggacctgaaagatgatggaaacatggtgaaagtattgcgggcacatcagaattgggtgtacagttgtgcattc
960 980 1000 1020
39 -------------------------------------------------------------------------------------- -
11d 7©y r 77yti a ©Ql ©01 :©ur ©4 1 L7 aV/ f il M CI ® +®I au aaa aLG ©1 7 1 1 1 ©l ©
W S B 1 i7 7iic7 a ii ©©s V u ii a J u ®a ©sai au Yl
tctcccgactgttctatgctgtgttcagttggcgccagtaaagcagttttcctttggaatatggataaatacaccatgattaggaa
73
1040 * 1060 1080 1100 11
39 -------------------------------------------------------------------------------------- -
11d ...Ra..®B.a®.aa.aa©auaIIaaaaaIIIaaa..a..a..©...0I.
gctggaaggtcatcaccatgatgttgtagcttgtgacttttctcctgatggagcattgctagctact gcatcc tatgacactcgtg
20 1140 * 1160 * 1180 1200
39 ----------------------------------------- -------------------------------------
11d ...... 1sia"S u.2.a.aa.a4.©....aaaI!I9.11aIaa -
W S B 1 .yi321aZIT123aaaaaI.auu.waIaIIIaIaIIIaa
tgtatgtctgggatccaca ca at ggagacc ttctgat ggagtttgggca cc tgtttccc tcgcc cactcc aat at ttgctggagga
* 1220 1240 1260 1280
39 -------------------------------------------------------------------------------------- -
11d ..... au...".6...©......©IaIaIaaa...a..a..aZsiaa.s.a.aaa
WSB1
gcaaatgaccgat9ggtgagagctgtgtctttcagtcatgatggactgcatgttgccagccttgctgatgataaaatggtgaggtt
1300 1320 1340 1360
39 ------------------- --------------- ---------- ------- -
WSB1 : aaII.f..a...a0..®.®I®1..aZa.a..aaaZI.IIaaIu.'a..aIZaoaa
ctggagaatcgatgaggattgtccggtacaagttgcacctttgagcaatggtctttgctgtgccttttctactgatggcagtgttt
1380 * 1400 1420 * 1440 1460
39 ---------------------- ---- ------------------------- -
11d TUOa aj 1 u1119146 ..uIe ".e ss5a I ",e 111, IaaaI.I.II.saIS..111 .111
W S B 1 ..aa-aCau.a.a.I.a..aISII ".e a IT BiI ua a a ..'. E s3a 1111111 %, Ze 'Mum
tagct g tgggacacatgatggaagtgtgtatttttgggccactccaaggcaagtccctagccttcaacatatatgtc9catgtc
* 1480 1500 * 1520 1540
39 -------------------------------------------------------------------------------------- -
11d ..I.....u.....I...6.0....uaiu1a1.ii..181111Z8Bs.IB.®...
aatccgaagagtgatgtccacccaagaagtccaaaaactgcctgttccttccaaaatattggcgtttctctcctaccgcggttag
74
1560 * 1580 1600 1620
39 -------------------------------------------------------------------------------------- -
I I d CT GAAGACTGCCTTTCC TGGTAGGCCTGC CAGACAGAGCGCCCTTTACAAGACACACCTCAAGCTTTACCAGCTCAAGCGTCTGTC 1634
WSB1 -------------------------------------------------------------------------------------- '
1640 1660 1680 * 1700 1720
39 -------------------------------------------------------------------------------------- -
11d CTTGGAGGCTCAGCAGATTTATTTAATTGGAATCCACTCTTATTCTTCATTTCATTAGTTGGACTTTTAAAGCATTAT TTATACAC 1720
WSB1 ------------------------------- --------------- '
1740 1760 1780 1800
39 ---------------------------------------------- ------- ----- ----------- -
11d CATAGAAATATTT CT GAACATATCAT GTAATTTTT TTAAGATAACTGTGAAAACATTACAT ACAT GTAT AT AT TTAGACATGAG CT 1806
WSB1 ------------------------------- --- ------------------------ -
1820 1840 1860 1880
39 -------------------------------------------------------------------------------------- -
11d GC TGC TAT ATATTGAATGGGCCCT TTAG TTTTCTCTTAGTTCTGACCTGTATATATTGC TTTAATAGAGCCAC GATT TGTAT AT GT 1892
WSB1 ---------------------------- 
-
1900 1920 1940 * 1960 * 19
39 --------------------------------------------------------------------------- 
-
11d GCTGTTCATTAGAGCAAATTCAGGGGAATTTTTGTTCTTTTTTTTTTTATTTGGGGGCACTAAGTTTAGATGAGATGAATTGCCTC 
1978
W S B 1 -------------------------------------------------------------------------------------- -
80 2000 2020 2040 
2060
39 -------- AA6CT© Qu i i©a ©ui 0©Bi airi u © i .
11d
WSB1 --- ---- -------------------------------------------------------------------
g ttggtcaggatagatggtgtgaaactgataagaggttttggatgtgaaaaagagtttccaaaagaatggtgtc
75
* 2 0 8 0 2100 2120 2190
39 © Q ©gQQ111 a:®1 s©0::::::aRs1aaII aIIIIIIIIaIIIa21121
11d 7.4 aI®'_©I QQQam 113111 aIIIIIM. a I I I I a a I I I I I
WSB1 --------------------------------------------------------------------------------------
tgggagtttgaatgtgatgattaaaaaaagagccaaggaaaaaggtagctagaaaaaaaggttggctctcatcagccttaattttg
2160 2180 * 2200 2220
3 9
11d ®HIIloilo IIa9a821111©aI©©I©0::©©©o
W S B 1 --------------------------------------------------------------------------------------
gaaagcagctacttacccctcagagaataaagtattatgca ttcttgtcaatttgaaaa a a t
2290 2260 2280 2300 2320
39 ------------------- 
------------------------ -------------- -
11d TTTTGTTAATACTAAGGGACAATTATTTTAAGACCATGGGTTTTGTTTTTAACATATTTTAT TT CT GCAGAGGATATTGGTAACTT 2322
W S B 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -- - - - - - - - - - - - - - -
2340 2360 2380 2900
39 ------------------ ---------------------------------------------- 
-
11d ACCAAAGAGAAGCAATACACAGTATGTCTGCTTTAGCCTTCTTTTATTTATCTCATCTGCAGATGTTGAGAATGTATGCATTATGT 2908
W S B 1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
* 2920 2990 * 2960
39 ------------------------------------------------------- 
-
11d AAAATGCTTGTTTTTTTATCCCTGTTGAGTTTTTTTAATTAAACGACACAAAACT 2963
WSB1 -------------------------------------------
76
